Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3000242	li-tau	ng/l (ng/l)	1637	1669	0.36%
3000242	li-tau	— (—)	675	691	100.00%	Distribution not available
3000242	li-tauproteiini,likvor	ng/l (ng/l)	6	6	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Dementia, including avohilmo

953

462

14.89

307.65

1.0

373.24

303.15

ng/l

2.75

698

288

Psychiatric diseases

978

687

7.21

307.65

1.0

330.90

336.70

ng/l

0.04

693

487

Organic, including symptomatic, mental disorders

1099

504

16.47

307.65

1.0

366.30

290.74

ng/l

3.67

787

334

Condition for Implicit Sepsis (Organ dysfunction codes)

1248

907

10.23

307.65

1.0

297.57

388.69

ng/l

1.14

1012

536

Hydrocephalus

355

128

31.37

307.65

1.1

1.0

251.31

334.16

ng/l

1.62

106

Implicit Sepsis

835

1206

5.47

307.65

1.0

288.55

364.72

ng/l

1.47

678

780

Normal-pressure hydrocephalus

330

47.23

307.65

1.1

1.0

249.57

356.46

ng/l

1.67

Alzheimer disease

610

344

13.96

307.65

1.0

416.05

297.75

ng/l

9.35

449

194

Any dementia, excluding more controls

789

337

17.05

307.65

1.0

395.40

308.57

ng/l

4.64

586

206

Any dementia

791

430

13.55

307.65

1.0

395.48

289.33

ng/l

7.94

588

254

Degenerative diseases of the nervous system

755

404

14.76

307.65

1.0

390.12

291.66

ng/l

8.50

567

237

N06DA Anticholinesterases

674

420

13.59

307.65

1.0

402.44

296.62

ng/l

9.56

490

255

Alzheimer disease, including avohilmo

698

391

13.46

307.65

1.0

413.56

285.93

ng/l

13.08

505

229

Other mental disorders due to brain damage and dysfunction and to physical disease

353

131

29.20

307.65

1.0

303.85

265.68

ng/l

0.87

237

Alzheimer disease, excluding more controls

592

67.47

307.65

1.0

413.79

413.21

ng/l

0.00

440

Alzheimer’s disease (Late onset)

375

233

14.32

307.65

1.0

430.45

297.22

ng/l

7.15

271

131

Alzheimer’s disease, wide definition, excluding more controls

540

77.49

307.65

1.0

419.29

334.95

ng/l

2.36

404

Symptoms and signs involving cognition, perception, emotional state and behaviour

1386

824

12.05

307.65

1.0

328.54

329.39

ng/l

0.01

1106

478

Other symptoms and signs involving cognitive functions and awareness

1260

506

24.72

307.65

1.0

328.20

362.59

ng/l

0.51

1045

282

Dementia

895

376

17.20

307.65

1.0

383.04

282.11

ng/l

8.78

652

236

Other degenerative diseases of the nervous system

748

179

33.39

307.65

1.0

385.82

363.53

ng/l

0.25

564

139

Unspecific neurodegenerative disorder

845

420

14.50

307.65

1.0

396.79

282.97

ng/l

10.95

610

253

Use of anticholinesterases

674

420

13.59

307.65

1.0

402.44

296.62

ng/l

9.56

490

255

Alzheimer’s disease (Late onset), excluding more controls

368

60.21

307.65

1.0

427.67

343.56

ng/l

1.78

266

Alzheimer’s disease (Early onset)

194

51.39

307.65

1.0

417.95

251.05

ng/l

4.51

150

Alzheimer’s disease, wide definition

547

273

17.62

307.65

1.0

421.23

295.13

ng/l

8.74

409

159

Use of donepezil

403

290

14.02

307.65

1.0

425.15

321.26

ng/l

5.27

303

171

Any mental disorder

924

882

5.30

307.65

1.0

332.37

334.99

ng/l

0.02

666

605

Dementia in Alzheimer disease

264

136

17.14

287.51

1.0

426.20

286.37

ng/l

4.29

162

Use of memantine

357

340

9.43

276.63

1.0

442.55

310.77

ng/l

7.55

252

193

Use of other anti-dementia drugs

357

340

9.43

276.63

1.0

442.55

310.77

ng/l

7.55

252

193

Use of rivastigmine

249

224

11.58

237.43

1.0

388.42

318.17

ng/l

2.20

184

134

Other neurological diseases

650

1323

4.00

210.77

1.1

1.0

360.03

332.27

ng/l

0.14

345

1022

Memory loss

170

107

16.65

200.58

1.0

314.33

260.57

ng/l

1.05

132

Depression or dysthymia

422

382

6.23

190.52

1.0

267.27

392.93

ng/l

0.67

294

264

Intracranial trauma

329

373

6.64

181.19

1.0

403.67

328.17

ng/l

0.27

217

296

Mood disorders, excluding more controls

567

851

4.08

171.61

1.0

251.41

332.87

ng/l

1.13

404

594

Neurological diseases

451

439

5.20

163.94

1.0

314.59

317.49

ng/l

0.04

316

345

Symptoms and signs involving the nervous and musculoskeletal systems

482

1271

3.84

157.75

1.0

275.96

357.99

ng/l

1.73

311

913

Unspecified dementia

140

15.80

152.00

1.0

344.35

302.34

ng/l

0.49

113

Circumscribed brain atrophy

37.25

143.91

1.0

292.73

197.91

ng/l

3.03

Concussion

252

363

6.05

135.86

1.0

435.58

325.93

ng/l

0.33

173

287

Dizziness and giddiness

387

751

4.21

135.64

1.0

306.20

338.71

ng/l

0.84

254

430

Other antidepressants

645

1145

2.96

116.20

1.0

285.73

370.69

ng/l

1.89

442

834

Parkinson's disease, excluding more controls

101

14.08

108.50

1.0

255.75

389.88

ng/l

0.95

Recurrent or chronic depression

199

220

6.58

107.28

1.0

246.95

423.32

ng/l

0.54

130

158

Undefined dementia

140

162

8.13

100.06

1.0

344.35

331.58

ng/l

0.15

113

Other and unspecified degenerative diseases of nervous system

26.82

98.96

1.1

1.0

317.27

199.57

ng/l

2.75

Parkinson's disease, strict definition, excluding more controls

14.16

98.42

1.1

1.0

251.97

395.94

ng/l

0.88

Abnormalities of gait and mobility

151

236

6.58

92.39

1.1

1.0

273.42

329.64

ng/l

0.43

152

Other symptoms and signs involving the nervous and musculoskeletal systems

308

867

3.59

91.90

1.0

269.61

326.90

ng/l

3.97

204

623

Medical observation and evaluation for suspected diseases and conditions

415

662

3.23

85.66

1.0

302.01

330.18

ng/l

0.84

248

523

Delirium, not induced by alcohol and other psychoactive substances

101

116

8.87

80.59

1.0

374.37

259.83

ng/l

0.93

Implicit bacterial Sepsis

274

714

3.56

78.82

1.0

274.87

350.36

ng/l

5.65

213

453

Anxiety disorders, excluding more controls

363

769

3.14

78.81

1.0

257.40

329.88

ng/l

0.85

277

543

Selective serotonin reuptake inhibitors

547

1145

2.53

74.71

1.0

290.36

370.69

ng/l

1.69

369

834

Alzheimer’s disease (Atypical or mixed)

9.25

72.40

1.0

1.1

380.00

268.57

ng/l

1.83

Mood [affective] disorders

570

1621

2.32

69.62

1.0

252.01

353.96

ng/l

4.37

407

1173

Mood disorders

569

1623

2.31

68.80

1.0

251.22

354.35

ng/l

4.48

406

1175

Schizophrenia or delusion, excluding more controls

150

316

4.74

65.43

1.0

272.55

277.06

ng/l

0.07

118

220

Bacterial Sepsis

277

790

3.15

65.37

1.0

276.51

344.52

ng/l

4.97

215

499

Viral Sepsis

150

322

4.72

64.90

1.1

1.0

309.46

366.87

ng/l

0.62

110

200

Depression

520

1551

2.32

64.04

1.0

256.85

352.09

ng/l

3.71

368

1131

Implicit viral Sepsis

148

321

4.67

63.24

1.1

1.0

310.07

367.61

ng/l

0.61

109

199

Use of galantamine

113

7.93

63.08

1.1

1.0

402.10

311.33

ng/l

1.67

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

151

140

5.43

57.54

1.0

274.24

341.03

ng/l

1.75

106

Extrapyramidal and movement disorders

258

875

2.98

57.00

1.0

258.61

340.86

ng/l

6.11

175

600

Vascular dementia

9.17

56.56

1.0

349.70

275.82

ng/l

0.99

Other and unspecified hydrocephalus

16.24

54.17

1.1

1.0

241.83

287.33

ng/l

0.46

Dementia in other diseases classified elsewhere

10.70

52.82

1.0

284.57

279.82

ng/l

0.03

Nonorganic sleeping disorders, excluding more controls

144

6.23

52.51

1.0

238.97

293.05

ng/l

1.27

100

Neurological diseases, wide definition

116

6.15

49.41

1.0

268.20

303.59

ng/l

0.46

General examination and investigation of persons without complaint and reported diagnosis

325

662

2.62

48.28

1.0

268.87

330.18

ng/l

3.31

213

523

Vascular dementia (subcortical)

17.28

48.10

1.1

1.0

378.67

231.20

ng/l

—

Substance abuse, excluding more controls

226

679

2.93

47.27

1.0

290.67

340.23

ng/l

0.41

168

476

Frontotemporal dementia, wide, incl. Pick's disease

31.08

47.27

1.0

256.78

243.40

ng/l

—

Traumatic subdural haemorrhage

108

6.81

47.17

1.0

284.81

324.99

ng/l

0.55

Epilepsy

188

596

3.17

46.48

1.0

279.91

335.88

ng/l

1.94

142

430

Malaise and fatigue

285

931

2.57

45.85

1.0

312.81

350.70

ng/l

1.01

202

654

Postprocedural disorders of nervous system

7.89

45.12

1.0

329.00

301.53

ng/l

0.22

Injuries to the head

530

1764

1.96

42.62

1.0

353.54

324.04

ng/l

0.17

371

1265

Benzodiazepine use

498

1803

1.97

41.39

1.0

281.97

344.56

ng/l

2.02

364

1274

Psychotic depression

13.50

38.26

1.0

176.24

285.53

ng/l

1.58

Depression medications

137

174

3.98

37.71

1.0

268.87

315.94

ng/l

1.05

137

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

226

4.27

37.06

1.0

247.91

276.14

ng/l

0.60

162

Intracranial injury

287

1229

2.27

36.44

1.0

419.14

334.06

ng/l

0.27

189

854

Bipolar affective disorders

105

268

3.95

36.44

1.0

217.08

341.00

ng/l

6.03

205

Unspecified mental disorder

213

840

2.55

35.35

1.0

238.67

318.86

ng/l

5.06

159

601

Kela-code for severe mental illness

197

759

2.61

34.35

1.0

236.00

319.45

ng/l

4.87

145

548

Personality disorders, excluding more controls

219

4.13

33.32

1.0

203.73

278.36

ng/l

3.69

159

Convulsions, not elsewhere classified

134

420

3.17

33.30

1.0

280.40

328.01

ng/l

1.17

302

Other extrapyramidal and movement disorders in other diseases

150

512

2.96

33.05

1.0

277.18

340.39

ng/l

2.69

104

357

Other special examinations and investigations of persons without complaint or reported diagnosis

297

662

2.28

32.70

1.0

312.03

330.18

ng/l

0.42

204

523

Fall on same level

527

1638

1.80

31.76

1.0

310.20

335.77

ng/l

0.50

371

1190

Persons encountering health services for examination and investigation

295

662

2.24

31.25

1.0

305.32

330.18

ng/l

0.63

201

523

Examination and observation for other reasons

250

660

2.31

30.03

1.0

296.15

330.18

ng/l

0.94

164

523

Focal epilepsy

130

433

3.03

29.91

1.0

279.63

318.90

ng/l

0.94

296

Use of levodopa decarboxylase inhibitor

105

319

3.34

28.31

1.0

271.70

330.26

ng/l

1.43

204

Other degenerative diseases of the basal ganglia

9.53

28.01

1.1

1.0

212.15

279.22

ng/l

1.39

Anxiety (asthma-related co-morbidities)

235

833

2.23

27.81

1.0

246.44

360.10

ng/l

1.90

177

613

General symptoms and signs

485

1366

1.78

27.62

1.0

286.51

353.00

ng/l

1.60

335

1000

Focal epilepsy, mode (most common among epilepsy diagnosis)

117

385

3.07

27.56

1.0

288.00

321.99

ng/l

0.70

264

Behavioural syndromes associated with physiological disturbances and physical factors

137

494

2.79

27.27

1.0

252.34

322.03

ng/l

3.02

354

Episodal and paroxysmal disorders

471

1356

1.78

27.02

1.0

293.85

338.20

ng/l

2.40

325

973

Other anxiety disorders

178

646

2.45

26.78

1.0

259.54

322.57

ng/l

2.36

131

471

Communicating hydrocephalus

9.50

26.66

1.2

1.0

293.91

280.27

ng/l

0.05

Focal epilepsy, strict definition

119

406

2.96

26.32

1.0

284.61

322.86

ng/l

0.83

276

Syncope and collapse

225

922

2.17

25.54

1.0

277.50

349.40

ng/l

3.68

147

651

Other symptoms and signs involving general sensations and perceptions

9.84

25.05

1.0

301.70

262.90

ng/l

—

Non-selective monoamine reuptake inhibitors

186

788

2.30

24.70

1.0

262.52

387.77

ng/l

2.03

129

584

STROKE

331

1222

1.89

24.34

1.0

292.04

361.70

ng/l

1.42

236

895

Parkinson's disease, including avohilmo

112

387

2.93

24.31

1.0

259.40

330.28

ng/l

2.53

254

Sleep disorders

109

371

2.96

24.25

1.0

251.47

320.46

ng/l

2.56

267

Cerebrovascular diseases

383

1551

1.78

23.38

1.0

308.94

342.61

ng/l

0.62

258

1096

Other disorders of urethra and urinary system

314

1272

1.86

22.36

1.0

302.36

362.71

ng/l

1.10

214

892

Metabolic disorders

443

1637

1.69

21.94

1.0

362.44

325.44

ng/l

0.19

327

1158

Schizophrenia, schizotypal and delusional disorders

151

639

2.38

21.77

1.0

272.55

316.80

ng/l

1.18

118

461

Schizophrenia or delusion

150

633

2.38

21.76

1.0

272.55

316.81

ng/l

1.18

118

458

Other and unspecified nonorganic psychotic disorders

298

3.07

21.70

1.0

263.52

311.69

ng/l

1.14

211

Headache

268

1172

1.92

21.55

1.0

283.46

350.32

ng/l

1.30

183

867

Hypothyroidism (congenital or acquired)

172

3.18

20.54

1.0

282.46

316.86

ng/l

0.46

136

All anxiety disorders

235

960

1.98

20.54

1.0

246.44

347.81

ng/l

1.92

177

701

Hypothyroidism and >3 levothyroxin purchases

172

3.15

20.05

1.0

296.76

316.86

ng/l

0.22

136

Hypothyroidism, levothyroxine purchases

172

3.15

20.05

1.0

296.76

316.86

ng/l

0.22

136

Sleep disorders (combined)

434

1736

1.64

19.78

1.0

363.21

328.42

ng/l

0.16

304

1242

Progressive vascular leukoencephalopathy

6.56

19.72

1.0

250.64

325.55

ng/l

0.86

Parkinson's disease

101

372

2.74

19.56

1.0

255.75

333.68

ng/l

2.72

242

Disorders of lipoprotein metabolism and other lipidaemias

414

1581

1.65

19.09

1.0

282.66

326.81

ng/l

2.88

310

1115

Infections, IBD-co-morbidities

4.42

19.09

1.0

282.69

310.09

ng/l

0.31

Nonorganic sleeping disorders

323

2.77

17.73

1.0

238.97

317.62

ng/l

2.91

231

Anxiety disorders

365

1570

1.65

17.34

1.0

257.09

342.84

ng/l

2.96

279

1124

Parkinson's disease, strict definition

340

2.70

17.21

1.1

1.0

251.97

329.98

ng/l

2.41

219

Manic episode

7.63

17.00

1.0

208.71

310.81

ng/l

1.09

Neurotic, stress-related and somatoform disorders

359

1553

1.65

16.91

1.0

256.50

342.90

ng/l

2.95

273

1111

Abnormal involuntary movements

261

2.94

16.82

1.0

259.31

331.28

ng/l

1.42

181

Constipation

390

1745

1.60

16.57

1.0

294.46

345.86

ng/l

1.30

281

1236

Spondylopathies

354

1309

1.65

16.17

1.0

278.63

362.85

ng/l

2.22

221

970

Insomnia

269

2.85

15.92

1.0

255.28

329.97

ng/l

2.26

191

Pure hypercholesterolaemia

364

1513

1.62

15.86

1.0

274.88

331.84

ng/l

4.57

270

1055

Lower back pain or/and sciatica

421

1879

1.56

15.72

1.0

265.18

343.41

ng/l

3.15

268

1371

Other dorsopathies, not elsewhere classified

398

1317

1.60

15.65

1.0

280.92

361.97

ng/l

2.04

262

974

Dorsalgia

389

1317

1.60

15.60

1.0

268.47

361.97

ng/l

2.68

253

974

Other intervertebral disc disorders

350

1315

1.63

15.53

1.0

267.75

362.18

ng/l

2.68

243

973

Sequelae of injuries of head

100

4.16

15.38

1.0

276.08

256.95

ng/l

0.16

Schizoaffective disorder

133

3.65

15.07

1.0

207.11

298.40

ng/l

2.74

severe traumatic brain injury, does not include concussion

113

500

2.27

14.90

1.0

265.22

316.31

ng/l

1.31

332

Follow-up examination after treatment for conditions other than malignant neoplasms

159

512

2.04

14.70

1.0

546.85

325.80

ng/l

0.48

116

409

Generalized anxiety disorder

160

3.33

14.58

1.0

260.92

327.40

ng/l

1.22

109

Other disorders of ear

410

1776

1.54

14.57

1.0

404.40

316.27

ng/l

0.47

284

1280

Cerebrovascular diseases (FINNGEN)

179

666

1.93

14.47

1.0

295.83

340.18

ng/l

1.19

132

511

Open wound of head

209

1156

1.79

14.04

1.0

296.11

332.58

ng/l

1.15

148

811

Factors influencing health status and contact with health services

140

328

2.15

13.79

1.0

301.75

352.90

ng/l

0.84

261

Viral infections of the central nervous system

118

3.68

13.72

1.0

735.32

300.31

ng/l

1.10

Monoamine oxidase A inhibitors

200

2.97

13.44

1.1

1.0

333.20

358.73

ng/l

0.23

149

Focal brain injury

5.23

13.42

1.0

240.07

293.56

ng/l

0.60

Statin medication

262

871

1.69

13.11

1.0

283.95

364.32

ng/l

1.17

186

654

Care involving use of rehabilitation procedures

283

1669

1.61

13.05

1.0

398.38

317.33

ng/l

0.33

240

1157

Dorsopathies

395

1318

1.53

13.01

1.0

287.36

361.79

ng/l

1.76

261

975

Falls/tendency to fall

424

1413

1.51

12.82

1.0

383.42

316.50

ng/l

0.36

302

1027

Other encephalitis

5.86

12.77

1.0

408.33

238.36

ng/l

0.98

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1171

0.38

12.61

1.0

261.13

331.20

ng/l

2.27

800

Speech disturbances, not elsewhere classified

176

3.04

12.56

1.0

275.89

309.26

ng/l

0.37

106

Sciatica+with lumbago

213

1180

1.72

12.52

1.0

256.74

359.76

ng/l

2.57

128

882

Pain in throat and chest

341

1345

1.55

12.41

1.0

377.29

336.46

ng/l

0.16

250

946

Low back pain

275

1314

1.62

12.34

1.0

263.27

362.17

ng/l

2.84

184

973

Viral encephalitis, not elsewhere classified/unspecified

6.15

12.18

1.0

345.86

292.04

ng/l

0.25

Other diseases of intestines

409

1607

1.48

11.89

1.0

293.03

338.38

ng/l

1.02

292

1149

Encephalitis

5.44

11.86

1.0

408.33

227.08

ng/l

1.07

Disorders of thyroid, IBD co-morbidities

3.49

11.74

1.0

273.50

289.57

ng/l

0.15

Parasetamol

297

952

1.60

11.70

1.0

281.61

323.46

ng/l

1.88

205

729

Shoulder lesions

344

1382

1.53

11.67

1.0

299.83

349.27

ng/l

0.93

245

986

Abnormal findings on diagnostic imaging of central nervous system

4.01

11.49

1.1

1.0

271.79

285.04

ng/l

0.06

Other reaction to severe stress, and adjustment disorders

122

619

1.98

11.38

1.0

256.81

321.91

ng/l

2.63

454

Degeneration of the brain due to alcohol

5.65

11.22

1.0

340.73

216.41

ng/l

1.02

Somnolence, stupor and coma

5.58

11.18

1.0

240.57

326.69

ng/l

0.41

Poisoning by drugs, medicaments and biological substances

405

2.21

11.09

1.0

251.80

324.60

ng/l

2.58

292

Poisoning by medicine

361

2.28

11.06

1.0

251.02

326.68

ng/l

2.58

261

Conductive and sensorineural hearing loss

357

1665

1.49

10.99

1.0

426.86

320.40

ng/l

0.49

243

1185

Alcohol abuse, main dg, excluding more controls

164

2.94

10.84

1.0

258.69

268.42

ng/l

0.11

111

Persons encountering health services for specific procedures and health care

416

1787

1.44

10.80

1.0

396.02

314.13

ng/l

0.50

324

1248

Lumbar disc prolapse

258

1298

1.58

10.80

1.0

271.38

361.95

ng/l

2.39

175

967

Symptoms and signs involving speech and voice

142

780

1.83

10.46

1.0

300.51

331.51

ng/l

0.68

115

535

Dysphagia

117

604

1.95

10.45

1.0

268.90

335.92

ng/l

2.06

408

246

1399

1.58

10.38

1.0

295.48

314.73

ng/l

0.54

179

995

Sequelae of cerebrovascular disease

153

753

1.79

10.32

1.0

337.91

334.00

ng/l

0.04

109

506

Transient ischemic attack

235

1224

1.60

10.26

1.0

280.36

340.52

ng/l

3.27

163

826

Alcohol use disorder, Swedish definition

227

1322

1.60

10.15

1.0

292.15

313.50

ng/l

0.59

165

946

Disorders of adult personality and behaviour

467

2.06

10.12

1.0

205.20

316.66

ng/l

9.01

348

233

1353

1.59

10.06

1.0

296.20

314.17

ng/l

0.47

172

961

Other diseases of urinary system

396

1549

1.44

10.01

1.0

315.81

342.80

ng/l

0.38

283

1097

Other headache syndromes

153

872

1.76

9.97

1.0

529.00

326.61

ng/l

0.36

101

631

Hyperkinetic disorders, excluding more controls

8.45

9.90

1.0

1.1

198.77

204.70

ng/l

—

Mental and behavioural disorders due to psychoactive substance use

234

1408

1.57

9.80

1.0

294.34

312.75

ng/l

0.50

175

1009

Sensorineural hearing loss

337

1613

1.47

9.71

1.0

434.30

323.08

ng/l

0.48

228

1145

Use of hypnotics and sedatives

425

1743

1.41

9.70

1.0

274.13

346.18

ng/l

2.39

317

1229

Cervicalgia

429

2.08

9.65

1.0

279.02

350.84

ng/l

1.54

316

Persistent mood disorders

352

2.20

9.56

1.0

265.15

349.41

ng/l

2.46

258

Mental and behavioural disorders due to alcohol

207

1260

1.60

9.48

1.0

303.43

309.79

ng/l

0.12

153

904

Traumatic subarachnoid haemorrhage

6.21

9.47

1.1

1.0

273.36

254.50

ng/l

0.17

Cerebral cysts

3.89

9.41

1.0

1658.40

311.00

ng/l

0.51

Superficial injury of head

414

2.09

9.36

1.0

275.82

335.72

ng/l

1.19

286

Other sleep disorders

220

2.52

9.26

1.0

333.78

326.19

ng/l

0.06

156

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1210

0.46

9.21

1.0

364.46

332.50

ng/l

0.25

828

Malignant neoplasm of digestive organs

1047

0.38

9.20

1.0

261.14

332.34

ng/l

1.80

702

Substance abuse

226

1393

1.55

9.07

1.0

290.67

311.51

ng/l

0.60

168

999

Other soft tissue disorders, not elsewhere classified

327

1389

1.46

8.98

1.0

281.61

348.54

ng/l

1.45

231

989

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

491

1.96

8.87

1.0

247.91

316.21

ng/l

2.50

360

Spinal stenosis

225

1137

1.56

8.80

1.0

287.85

375.35

ng/l

1.66

137

834

Nerve, nerve root and plexus disorders

412

1866

1.39

8.75

1.0

300.12

337.65

ng/l

0.92

303

1318

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

721

0.28

8.73

1.1

1.0

460.50

341.74

ng/l

0.34

487

Anaemias

172

2.40

8.70

1.0

301.02

316.86

ng/l

0.15

136

Diseases of oesophagus, stomach and duodenum

411

1800

1.39

8.68

1.0

308.36

335.73

ng/l

0.56

306

1272

Hypertension, essential

321

1261

1.46

8.66

1.0

408.38

322.84

ng/l

0.35

237

919

Mental and behavioural disorders due to alcohol, excluding acute intoxication

185

1155

1.60

8.59

1.0

303.23

304.24

ng/l

0.02

137

836

Hyperplasia of prostate

183

635

1.65

8.58

1.0

294.37

299.31

ng/l

0.09

134

433

Secondary parkinsonism+Parkinsonism in other disease

4.22

8.49

1.0

235.78

350.22

ng/l

—

Other lack of coordination

5.89

8.36

1.2

1.0

256.17

235.86

ng/l

—

Persistent delusional disorders

155

2.73

8.34

1.0

338.52

298.29

ng/l

0.34

Personality disorders

461

1.96

8.31

1.0

203.73

318.83

ng/l

9.00

339

Non-invasive ventilation

421

1.97

8.19

1.1

1.0

252.78

362.88

ng/l

3.60

309

Stroke, including SAH

270

1359

1.47

8.17

1.0

323.68

329.21

ng/l

0.09

179

940

Migraine without aura

222

2.39

8.12

1.0

274.89

325.39

ng/l

0.69

161

Sleep apnoea

365

1780

1.39

8.04

1.0

382.27

323.14

ng/l

0.25

256

1279

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

658

0.34

7.80

1.0

294.36

343.46

ng/l

0.71

434

Suicide or other Intentional self-harm

472

1.91

7.79

1.0

248.90

316.14

ng/l

2.22

345

Heart failure and coronary heart disease

692

0.40

7.68

1.0

291.52

347.22

ng/l

0.88

448

Sleep apnoea, including avohilmo

379

1792

1.37

7.67

1.0

377.70

324.82

ng/l

0.23

264

1288

Other functional intestinal disorders

175

1056

1.58

7.67

1.0

300.83

370.03

ng/l

0.91

127

726

Disturbances of smell and taste

4.76

7.64

1.1

1.0

332.80

259.57

ng/l

—

Symptoms and signs involving the urinary system

307

1683

1.41

7.52

1.0

328.79

336.11

ng/l

0.08

224

1169

Secondary parkinsonism

3.95

7.46

1.0

243.50

308.06

ng/l

—

Alcohol use disorder, ICD-based

168

1065

1.58

7.43

1.0

304.37

299.65

ng/l

0.08

124

763

Diseases of the ear and mastoid process

432

1625

1.35

7.37

1.0

387.74

313.02

ng/l

0.41

301

1173

Restless leg syndrome

271

2.19

7.36

1.0

266.74

342.77

ng/l

2.62

175

Degeneration of nervous system due to alcohol

3.90

7.29

1.0

340.73

257.00

ng/l

0.65

Other external causes of accidental injury

306

1078

1.42

7.26

1.0

308.31

325.24

ng/l

0.45

224

749

Pain in limb

274

1384

1.43

7.24

1.0

266.68

348.83

ng/l

2.15

194

987

Hypertensive diseases (excluding secondary)

199

751

1.54

7.23

1.0

309.16

329.90

ng/l

0.22

146

577

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

127

2.77

7.19

1.1

1.0

264.61

320.28

ng/l

0.97

Inflammatory diseases of the central nervous system

169

2.50

7.08

1.1

1.0

351.46

287.40

ng/l

0.43

109

Colorectal cancer, excluding all cancers (controls excluding all cancers)

832

0.41

7.06

1.0

261.54

353.18

ng/l

2.74

555

Unspecified fall

174

1122

1.54

6.92

1.0

490.29

324.41

ng/l

0.37

126

777

Cardiodefibrillation

1100

0.48

6.91

1.0

256.41

329.99

ng/l

2.75

752

Hypertensive diseases

312

1264

1.40

6.91

1.0

406.55

322.53

ng/l

0.33

231

921

Hypertension

312

1264

1.40

6.90

1.0

406.55

322.53

ng/l

0.33

231

921

Bleeding

334

1775

1.37

6.85

1.0

298.93

341.33

ng/l

0.96

221

1269

Type 2 diabetes, wide definition

339

1615

1.37

6.81

1.0

283.71

349.88

ng/l

1.81

241

1157

Mixed and other personality disorders

126

2.72

6.76

1.0

209.30

275.60

ng/l

1.94

Stroke, excluding SAH

248

1285

1.44

6.70

1.0

328.31

331.52

ng/l

0.05

166

887

Spondylosis

216

1265

1.47

6.66

1.0

292.30

367.27

ng/l

1.37

130

938

Persons encountering health services in other circumstances, wide

449

1774

1.31

6.60

1.0

264.16

351.73

ng/l

3.51

351

1224

Rotator cuff syndrome

260

1366

1.42

6.50

1.0

310.29

351.54

ng/l

0.64

186

973

Injuries to the thorax

167

1092

1.53

6.50

1.0

282.10

332.36

ng/l

1.32

115

768

Endocrine, nutritional and metabolic diseases

277

998

1.41

6.42

1.0

284.10

335.28

ng/l

2.14

200

732

Covid-19 confirmed case

101

586

1.73

6.38

1.1

1.0

309.73

323.59

ng/l

0.22

396

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

261

2.12

6.36

1.0

235.35

304.34

ng/l

1.92

187

Transient global amnesia

142

2.55

6.35

1.0

327.70

269.32

ng/l

0.55

Diseases of male genital organs

205

694

1.50

6.35

1.0

273.63

291.67

ng/l

0.47

157

482

Heart failure, strict

115

1347

0.61

6.34

1.0

250.21

336.07

ng/l

5.75

907

Hypotension

343

1.96

6.32

1.0

273.45

323.90

ng/l

1.05

215

Cervical disc disorders

150

966

1.56

6.28

1.0

298.86

366.28

ng/l

0.86

107

721

Heart failure,strict

107

1275

0.60

6.28

1.0

251.00

337.50

ng/l

5.13

880

GASTRO-related operations

282

1009

1.40

6.27

1.0

309.18

318.78

ng/l

0.21

184

793

Any gastric operation

282

1009

1.40

6.27

1.0

309.18

318.78

ng/l

0.21

184

793

Pain (limb, back, neck, head abdominally)

279

996

1.41

6.24

1.0

296.65

337.09

ng/l

1.48

190

725

Accidents

298

1078

1.39

6.17

1.0

304.31

325.24

ng/l

0.61

221

749

Fever of other and unknown origin

179

1112

1.49

6.16

1.0

285.74

368.44

ng/l

1.44

120

798

Dental operations

266

971

1.41

6.06

1.0

317.68

315.08

ng/l

0.05

176

675

Provisional assignment of new diseases of uncertain etiology

141

904

1.56

6.03

1.0

298.27

316.71

ng/l

0.39

109

628

Soft tissue disorders

358

1390

1.34

6.02

1.0

291.49

348.38

ng/l

1.20

249

990

Codes for special purposes

141

905

1.56

6.00

1.0

298.27

316.62

ng/l

0.39

109

629

All-cause Heart Failure

115

1325

0.62

5.91

1.0

255.44

337.17

ng/l

5.05

888

Diabetes medication

376

1734

1.32

5.90

1.0

289.26

343.18

ng/l

1.42

271

1244

Other and unspecified polyneuropathies, also in other diseases

489

1.77

5.88

1.0

255.03

322.02

ng/l

2.86

327

Phobic anxiety disorders

125

2.57

5.77

1.0

226.44

309.41

ng/l

1.63

Specific personality disorders

384

1.85

5.71

1.0

207.86

323.52

ng/l

6.86

282

COPD, hospital admissions 1, only main diagnosis

852

0.51

5.63

1.0

344.33

329.20

ng/l

0.11

570

Disturbance of activity and attention

4.59

5.62

1.0

198.77

217.19

ng/l

0.23

Parodontitis and operation codes

332

1950

1.33

5.61

1.0

296.95

336.88

ng/l

0.98

245

1388

Fracture of skull and facial bones

430

1.80

5.60

1.0

243.56

319.19

ng/l

3.01

303

Status epilepticus

3.31

5.59

1.0

271.71

320.50

ng/l

0.37

Fracture of rib(s), sternum and thoracic spine

117

733

1.60

5.57

1.0

283.68

322.71

ng/l

0.66

506

Migraine

132

720

1.56

5.54

1.0

258.38

324.28

ng/l

2.49

529

249

2.06

5.53

1.0

227.65

361.50

ng/l

6.26

164

Other CVD (FINNGEN)

241

1.97

5.53

1.1

1.0

273.00

396.30

ng/l

2.45

166

Hypersomnia

4.89

5.52

1.1

1.0

318.20

232.07

ng/l

—

COPD, hospital admissions

1179

0.59

5.51

1.0

307.71

340.19

ng/l

0.42

795

Influenza and pneumonia

370

1865

1.31

5.50

1.0

264.46

343.71

ng/l

3.12

265

1339

Parodontitis or operation codes

346

1944

1.31

5.44

1.0

296.71

337.24

ng/l

1.01

251

1384

External causes of morbidity and mortality

241

862

1.40

5.40

1.0

310.98

332.40

ng/l

0.51

175

596

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

568

0.37

5.40

1.0

246.38

334.18

ng/l

2.63

370

COPD, early/later onset

1189

0.59

5.38

1.0

306.06

339.84

ng/l

0.46

804

Alcohol dependence

110

686

1.61

5.36

1.0

294.15

305.75

ng/l

0.18

486

COPD, hospital admissions 3, with asthma pneumonia sepsis

628

0.45

5.34

1.1

1.0

265.70

326.18

ng/l

0.95

408

Parodontitis

345

1945

1.31

5.33

1.0

296.71

337.24

ng/l

1.01

251

1384

Sequelae of injuries, of poisoning and of other consequences of external causes

534

1.69

5.32

1.0

278.03

314.66

ng/l

0.81

380

Genitourinary diseases

220

778

1.42

5.29

1.0

288.27

304.46

ng/l

0.41

160

550

COPD related to multimorbidity

984

0.56

5.21

1.0

285.08

342.70

ng/l

1.00

658

Dental caries 3, only avohilmo

321

1237

1.33

5.18

1.0

318.40

321.33

ng/l

0.06

224

866

Migraine without aura and triptan purchases

176

2.22

5.17

1.0

256.93

322.89

ng/l

1.31

126

Dental operations, only avohilmo

274

1033

1.36

5.17

1.0

307.29

315.95

ng/l

0.19

184

722

Dental pulpitis 2, only avohilmo

284

1076

1.35

5.16

1.0

330.31

320.46

ng/l

0.21

198

750

Chronic periodontitis, including avohilmo

342

1947

1.30

5.08

1.0

297.26

336.87

ng/l

0.97

248

1386

Later onset COPD

612

0.47

5.08

1.1

1.0

263.75

336.18

ng/l

1.29

377

Diseases of the musculoskeletal system and connective tissue

172

586

1.47

5.06

1.0

286.91

323.27

ng/l

0.97

113

429

Colorectal cancer

635

0.42

5.03

1.0

258.17

327.19

ng/l

1.83

420

Cervicocranial syndrome

218

2.07

5.02

1.0

267.32

352.76

ng/l

1.27

160

Dental caries, including avohilmo

304

1168

1.33

5.01

1.0

318.98

323.15

ng/l

0.08

212

815

Disorders of lens

300

1429

1.33

4.99

1.0

312.67

350.97

ng/l

0.67

211

1037

Hyperkinetic disorders

4.15

4.99

1.0

198.77

212.30

ng/l

0.17

Dental caries 1

304

1169

1.33

4.98

1.0

318.98

323.03

ng/l

0.08

212

816

Ischaemic Stroke, excluding all haemorrhages

223

1222

1.38

4.98

1.0

319.95

337.84

ng/l

0.32

150

826

Hypothyroidism, strict autoimmune, 3 medication purchases required

294

1514

1.33

4.95

1.0

290.23

351.25

ng/l

1.47

187

1092

Injuries to the shoulder and upper arm

301

1921

1.32

4.94

1.0

417.35

319.07

ng/l

0.38

214

1362

Dental caries 1, only avohilmo

308

1189

1.33

4.94

1.0

314.36

323.15

ng/l

0.20

214

831

Oter anti-inflammatory and antirheumatic agents, non-steroids

307

1.69

4.92

1.0

253.51

336.33

ng/l

3.05

217

All influenza

557

1.64

4.82

1.0

243.29

332.49

ng/l

3.94

391

Diabetes mellitus

366

1701

1.29

4.82

1.0

276.91

344.42

ng/l

2.06

262

1219

Other chronic obstructive pulmonary disease

1137

0.61

4.81

1.0

306.06

339.89

ng/l

0.46

768

COPD, hospital admission 2, with asthma infections

764

0.52

4.81

1.0

287.28

326.62

ng/l

0.33

508

Cystitis

285

1315

1.33

4.75

1.0

313.86

361.55

ng/l

0.63

204

920

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

354

1.79

4.69

1.0

259.74

311.98

ng/l

1.27

253

Other problems related to primary support group, including family circumstances

117

2.42

4.68

1.0

249.04

311.79

ng/l

0.98

Acute and transient psychotic disorders

218

2.03

4.65

1.0

253.63

318.32

ng/l

1.01

149

Diabetes, varying definitions

364

1703

1.28

4.61

1.0

277.70

344.19

ng/l

2.01

261

1220

Other bacterial diseases

346

1867

1.28

4.61

1.0

288.49

340.34

ng/l

1.49

243

1338

Colorectal adenocarcinoma

526

0.40

4.60

1.0

246.38

328.65

ng/l

2.39

346

Anomalies of pupillary function

4.45

4.57

1.0

225.33

315.67

ng/l

—

Diseases of the myoneural junction and muscle

283

1.88

4.53

1.0

313.51

316.31

ng/l

0.02

191

Dental pulpitis 2

274

1057

1.33

4.50

1.0

333.88

321.74

ng/l

0.26

188

732

Dental caries 3

310

1216

1.30

4.47

1.0

321.17

321.46

ng/l

0.01

217

850

Dystonia

105

2.49

4.46

1.1

1.0

255.10

327.75

ng/l

1.42

Cardiovascular diseases (excluding rheumatic etc)

184

755

1.41

4.45

1.0

273.89

329.32

ng/l

2.01

123

579

Exposure to unspecified factor

326

1974

1.28

4.44

1.0

315.53

333.20

ng/l

0.30

260

1379

Symptoms and signs involving the digestive system and abdomen

367

1444

1.27

4.42

1.0

306.74

319.25

ng/l

0.34

260

1027

Transport accidents

144

880

1.45

4.42

1.0

280.42

310.07

ng/l

0.65

108

608

Abnormalities of breathing

295

1345

1.30

4.39

1.0

374.91

336.46

ng/l

0.12

211

946

COPD

1172

0.64

4.38

1.0

296.59

336.40

ng/l

0.63

797

Symptoms and signs involving the circulatory and respiratory systems

344

1345

1.28

4.38

1.0

277.80

336.46

ng/l

3.35

251

946

Symptoms and signs concerning food and fluid intake

176

2.11

4.36

1.1

1.0

287.16

308.82

ng/l

0.24

120

Dental caries 3 and operation codes

334

1335

1.29

4.32

1.0

315.36

319.39

ng/l

0.09

236

933

Migraine with aura

339

1.77

4.29

1.0

215.95

351.97

ng/l

5.91

243

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

549

0.44

4.24

1.0

269.93

334.85

ng/l

1.00

358

Hypothyroidism, strict autoimmune

263

1327

1.31

4.21

1.0

293.22

354.13

ng/l

1.19

168

944

Polyneuropathies and other disorders of the peripheral nervous system

563

1.59

4.19

1.0

257.05

316.81

ng/l

2.57

379

Gastro-oesophageal reflux disease

254

1719

1.31

4.17

1.0

305.02

338.76

ng/l

0.63

179

1214

All pneumoniae

347

1896

1.26

4.16

1.0

266.25

342.43

ng/l

2.93

250

1357

Oxycodone

1045

0.60

4.16

1.0

287.91

346.25

ng/l

0.56

711

Continuous positive airway pressure

380

1.66

4.06

1.0

342.57

367.38

ng/l

0.27

281

Cervicobrachial syndrome

497

1.61

4.06

1.0

226.34

401.70

ng/l

1.79

374

Hard cardiovascular diseases

329

1665

1.27

4.06

1.0

292.71

344.23

ng/l

1.23

225

1201

Other (not insulin) diabetes medications

360

1728

1.26

4.05

1.0

278.91

344.73

ng/l

1.95

257

1241

Postmenopausal osteoporosis with pathological fracture

117

2.33

4.02

1.0

288.47

352.12

ng/l

0.76

Biguanides

359

1764

1.26

4.01

1.0

275.72

345.77

ng/l

2.22

255

1271

Dental caries 1 and operation codes

322

1297

1.27

3.96

1.0

316.05

320.27

ng/l

0.09

223

905

Other chronic obstructive pulmonary disease, including avohilmo

116

1401

0.69

3.94

1.0

297.59

330.65

ng/l

0.56

951

Senile cataract

277

1331

1.29

3.92

1.0

314.28

358.24

ng/l

0.73

189

961

Cramp and spasm

2.58

3.89

1.1

1.0

328.47

281.42

ng/l

0.18

Other CVD

419

1.65

3.85

1.0

269.92

330.94

ng/l

1.52

271

Retention of urine

132

778

1.44

3.85

1.0

372.48

332.58

ng/l

0.31

512

Type 2 diabetes

357

1697

1.25

3.84

1.0

274.37

344.78

ng/l

2.20

256

1217

Fracture at wrist and hand level

108

728

1.49

3.82

1.0

312.27

309.58

ng/l

0.03

513

Schizophrenia

322

1.74

3.82

1.0

229.02

327.14

ng/l

4.46

235

Hypothyreosis and Thyroxine purchase for inclusion criteria

314

1641

1.26

3.78

1.0

289.84

350.33

ng/l

1.58

204

1180

Hernia

333

1804

1.25

3.75

1.0

282.01

341.64

ng/l

1.70

227

1299

Injuries to the abdomen, lower back, lumbar spine and pelvis

125

865

1.44

3.75

1.0

311.33

328.97

ng/l

0.21

598

Glucagon-like peptide-1 (GLP-1) analogues

222

1391

1.32

3.75

1.0

282.41

333.73

ng/l

2.03

150

968

Visual disturbances and blindness

167

1224

1.37

3.74

1.0

337.20

344.93

ng/l

0.05

118

846

Pain in joint

197

972

1.34

3.73

1.0

293.95

337.10

ng/l

1.48

151

716

Pedestrian injured in transport accident

128

2.20

3.70

1.0

316.58

294.95

ng/l

0.11

Other and unspecified myopathies

189

1.97

3.67

1.0

304.27

318.72

ng/l

0.12

118

Cardiovascular diseases

157

613

1.40

3.66

1.0

283.91

318.32

ng/l

0.91

110

479

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

346

1698

1.25

3.65

1.0

283.51

344.61

ng/l

1.66

253

1217

Hypoglycaemia, other or unspecified

116

2.25

3.64

1.1

1.0

349.95

290.79

ng/l

0.45

Diabetes, insulin treatment (Kela reimbursement)

365

1806

1.24

3.63

1.0

280.16

342.74

ng/l

1.87

265

1288

Injuries to the elbow and forearm

225

1563

1.30

3.61

1.0

329.55

338.10

ng/l

0.11

155

1110

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1138

0.67

3.61

1.0

366.04

350.75

ng/l

0.07

813

Injury, poisoning and certain other consequences of external causes

185

683

1.36

3.60

1.0

320.19

337.97

ng/l

0.33

129

488

Disorders of ocular muscles, binocular movement, accommodation and refraction

138

980

1.40

3.57

1.0

318.92

355.43

ng/l

0.35

701

Hypothyroidism, other/unspecified

303

1590

1.26

3.56

1.0

285.59

351.19

ng/l

1.73

199

1143

Certain infectious and parasitic diseases

353

1423

1.24

3.55

1.0

309.34

342.79

ng/l

0.48

253

1008

Emotionally unstable personality disorder

137

2.12

3.54

1.0

188.00

295.47

ng/l

3.05

Diarrhoea and gastroenteritis of presumed infectious origin

211

1468

1.31

3.50

1.0

299.90

332.15

ng/l

0.49

158

1014

Amyloidosis, other/unspecified

3.38

3.49

1.1

1.0

662.00

313.50

ng/l

1.50

Pneumonias (Asthma/COPD co-morbidities)

340

1904

1.24

3.48

1.0

268.16

342.11

ng/l

2.77

245

1362

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

335

1902

1.24

3.46

1.0

269.42

341.48

ng/l

2.63

241

1360

Diseases of the eye and adnexa

268

1050

1.28

3.44

1.0

313.10

338.57

ng/l

0.30

199

788

Any event in cancer register

230

1752

0.78

3.43

1.0

430.49

319.82

ng/l

0.32

166

1253

Other and unspecified injuries of head

2.35

3.41

1.0

332.44

274.65

ng/l

0.32

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

313

1573

1.25

3.40

1.0

266.84

356.97

ng/l

2.99

226

1123

313

1573

1.25

3.40

1.0

266.84

356.97

ng/l

2.99

226

1123

Volume depletion

174

1.96

3.38

1.0

269.62

340.08

ng/l

0.58

108

Migraine with aura and triptan purchases

167

1.98

3.38

1.0

225.38

316.39

ng/l

3.06

119

Other diseases of pleura

1142

0.67

3.37

1.0

336.21

332.52

ng/l

0.03

772

Later onset COPD, excluding more controls

504

0.54

3.35

1.0

242.54

372.27

ng/l

3.60

324

Somatoform disorder

291

1.72

3.32

1.0

265.56

347.46

ng/l

2.33

200

Used for control exclusion in common control thyroid runs

362

1494

1.23

3.32

1.0

289.70

344.93

ng/l

1.28

252

1077

Other specified/unspecified disorders of bone/cartilage

2.80

3.26

1.0

291.50

237.35

ng/l

—

Other/unspecified dorsalgia

117

825

1.41

3.26

1.0

264.50

377.12

ng/l

1.75

612

Meningitis

2.35

3.24

1.1

1.0

229.58

291.75

ng/l

0.46

Voice disturbances

616

1.48

3.24

1.0

310.25

344.25

ng/l

0.63

425

Fracture of forearm

182

1296

1.32

3.22

1.0

337.34

351.60

ng/l

0.16

126

923

Disorders of vestibular function (Vertigo)

168

1256

1.33

3.22

1.0

528.54

323.13

ng/l

0.43

114

870

Special screening examination for infectious and parasitic diseases

200

1.76

3.21

1.0

279.21

300.38

ng/l

0.30

169

Fracture of neck

123

2.13

3.20

1.1

1.0

402.61

293.04

ng/l

0.43

Disorders of eyelid, lacrimal system and orbit

294

1859

1.24

3.19

1.0

311.43

340.50

ng/l

0.55

203

1311

Injury of muscle and tendon at shoulder and upper arm level

141

1037

1.36

3.17

1.0

321.29

320.68

ng/l

0.01

103

733

Eating disorders

2.31

3.16

1.0

269.64

295.95

ng/l

0.17

Disorders of the thyroid gland

319

1693

1.23

3.15

1.0

286.99

347.48

ng/l

1.64

211

1220

Malignant neoplasm of colon

362

0.41

3.13

1.0

261.75

327.59

ng/l

—

234

Fall on same level involving ice and snow

190

1463

1.30

3.11

1.0

507.15

316.39

ng/l

0.44

125

1034

Exclusions for E4_PCOS_CONSORTIUM

211

1024

1.29

3.10

1.0

493.86

324.20

ng/l

0.52

161

733

Explicit Sepsis

110

746

1.42

3.10

1.0

300.00

357.38

ng/l

1.22

471

Abdominal and pelvic pain

351

1444

1.22

3.09

1.0

304.35

319.25

ng/l

0.43

254

1027

Diverticular disease of intestine

280

1494

1.25

3.08

1.0

318.86

347.21

ng/l

0.45

192

1062

Visual disturbances

153

1146

1.34

3.06

1.0

328.21

316.53

ng/l

0.09

109

795

Malignant neoplasm

235

1757

0.79

3.05

1.0

433.87

317.84

ng/l

0.35

170

1258

Pain, not elsewhere classified

519

1.51

3.03

1.0

247.06

347.83

ng/l

4.92

374

Fissure and fistula of anal and rectal regions

610

1.46

3.00

1.0

284.40

331.93

ng/l

1.19

438

Unstable angina pectoris

983

0.68

2.99

1.0

261.34

337.96

ng/l

3.11

670

Vascular syndromes of brain in cerebrovascular disorders

2.55

2.96

1.1

1.0

261.22

279.05

ng/l

—

Gastrointestinal diseases

200

772

1.30

2.95

1.0

312.18

330.95

ng/l

0.35

136

542

Disorders of choroid and retina

296

1754

1.23

2.95

1.0

337.40

338.67

ng/l

0.01

213

1228

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2.34

2.92

1.1

1.0

329.00

281.85

ng/l

—

Bacterial infection, other or unspecified

183

1275

1.30

2.92

1.0

286.26

332.56

ng/l

1.71

132

878

Fracture of lumbar spine and pelvis

475

1.52

2.92

1.0

358.49

336.79

ng/l

0.15

307

Type 2 diabetes, definitions combined

344

1694

1.21

2.90

1.0

282.40

345.11

ng/l

1.72

240

1215

Persons encountering health services for other counselling and medical advice, not elsewhere classified

374

1774

1.20

2.88

1.0

275.97

351.73

ng/l

2.65

290

1224

Other disorders of fluid, electrolyte and acid-base balance

105

722

1.41

2.86

1.0

568.53

346.84

ng/l

0.29

481

COPD (mode)

799

0.66

2.83

1.0

306.75

351.98

ng/l

0.54

542

Nontraumatic intracranial haemmorrhage

455

1.52

2.83

1.0

347.18

337.16

ng/l

0.08

300

Pneumonia, organism unspecified

305

1810

1.22

2.82

1.0

272.92

345.07

ng/l

2.38

215

1296

Diseases of inner ear

192

1473

1.28

2.79

1.0

535.69

315.01

ng/l

0.57

131

1035

Malignant neoplasm of liver and intrahepatic bile ducts

0.00

2.79

0.0

1.0

—

307.60

—

Other disorders of eye and adnexa

261

1.69

2.79

1.0

283.73

327.11

ng/l

0.50

174

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

0.00

2.78

0.0

1.0

—

323.16

—

In situ neoplasms

931

0.66

2.78

1.0

341.11

345.25

ng/l

0.04

617

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

233

1717

0.80

2.78

1.0

431.78

316.04

ng/l

0.35

173

1228

Malignant neoplasm, wide definition for exclusion

233

1717

0.80

2.78

1.0

431.78

316.04

ng/l

0.35

173

1228

Type 2 diabetes, strict (exclude DM1)

343

1700

1.21

2.74

1.0

282.40

345.86

ng/l

1.76

240

1220

Gingivitis and periodontal diseases

322

1369

1.22

2.73

1.0

297.28

325.79

ng/l

1.07

224

965

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

130

1197

0.75

2.73

1.1

1.0

299.11

336.52

ng/l

0.94

814

Finngen Rheumatological endpoints

329

1551

1.21

2.72

1.0

327.04

333.62

ng/l

0.07

241

1111

Irritable bowel syndrome

590

1.44

2.72

1.0

304.97

331.88

ng/l

0.46

417

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

132

1209

0.75

2.72

1.1

1.0

297.29

336.33

ng/l

1.05

825

Atherosclerosis, excluding cerebral and coronary sclerosis

995

0.71

2.71

1.0

328.22

340.13

ng/l

0.15

659

Peripheral arterial reconstruction

407

0.49

2.70

1.1

1.0

325.54

318.49

ng/l

0.03

259

3.00

2.70

1.0

246.83

284.36

ng/l

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

234

1717

0.80

2.69

1.0

431.78

316.04

ng/l

0.35

173

1228

Pain in thoracic spine

279

1.65

2.69

1.0

246.39

332.44

ng/l

2.27

209

Psoriasis

722

0.62

2.64

1.0

337.43

329.53

ng/l

0.05

519

Type 2 diabetes, definitions combined, including avohilmo

340

1678

1.20

2.62

1.0

275.21

347.21

ng/l

2.18

240

1203

Mixed conductive and sensorineural hearing loss

297

1.62

2.61

1.0

339.41

317.83

ng/l

0.23

201

Diplopia

297

1.62

2.61

1.0

242.97

323.40

ng/l

2.71

202

Other cataract

168

1008

1.29

2.61

1.0

318.84

338.11

ng/l

0.39

115

709

Oedema, not elsewhere classified

675

1.40

2.61

1.0

270.64

349.63

ng/l

2.97

482

Propionic acid derivatives

310

1.44

2.57

1.0

268.02

334.00

ng/l

1.18

220

Endovascular or surgical operations to intracerebral aneurysms

156

1.87

2.57

1.1

1.0

390.43

331.05

ng/l

0.29

101

Other disorders of nervous system

128

1.96

2.55

1.1

1.0

371.53

317.86

ng/l

0.19

Bacterial meningitis

2.44

2.54

1.1

1.0

227.67

294.51

ng/l

—

Tramadol

287

1521

1.21

2.53

1.0

270.66

331.82

ng/l

3.65

213

1076

Exclusions for E4_PCOS_BROAD

323

1.58

2.53

1.0

234.98

320.14

ng/l

2.74

222

Colonic or urogenital fistula

658

1.40

2.53

1.0

296.97

334.27

ng/l

0.81

465

Cardiomyopathy

525

0.57

2.51

1.0

298.63

329.96

ng/l

0.22

358

Other fall from one level to another

469

1.47

2.49

1.0

331.75

309.31

ng/l

0.16

327

Abnormal findings in secretions and smears from cervix uteri vagina vulva

749

0.68

2.47

1.0

322.70

371.56

ng/l

0.38

555

Diseases of oral cavity, salivary glands and jaws

320

1369

1.20

2.43

1.0

298.59

325.79

ng/l

1.02

223

965

Other gastritis (incl. Duodenitis)

580

1.42

2.41

1.0

339.25

328.28

ng/l

0.15

395

Disorders of synovium and tendon

171

1214

1.27

2.40

1.0

343.37

354.12

ng/l

0.11

131

874

Inguinal hernia

203

1096

1.25

2.40

1.0

276.35

318.38

ng/l

1.46

134

779

Other disorders starting during childhood or adolescence

4.97

2.38

1.0

218.75

276.57

ng/l

—

Benign paroxysmal vertigo

708

1.37

2.38

1.1

1.0

698.28

339.32

ng/l

0.43

496

Pleural effusion

401

0.52

2.38

1.0

321.43

327.17

ng/l

0.05

258

Disorders of other endocrine glands

124

925

1.32

2.37

1.0

262.74

328.57

ng/l

2.73

640

Substance use, excluding alcohol

353

1.53

2.36

1.1

1.0

230.36

311.80

ng/l

3.86

260

Heart failure and antihypertensive medication

530

0.66

2.36

1.0

245.36

347.02

ng/l

3.29

402

Heart failure and bmi 25plus

626

0.68

2.34

1.0

237.82

312.93

ng/l

3.88

421

Disorders of parathyroid gland

470

1.45

2.33

1.0

272.91

344.62

ng/l

1.99

316

Superficial injury of abdomen, lower back and pelvis

283

1.59

2.33

1.0

230.12

318.48

ng/l

2.70

189

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4.07

2.33

1.0

213.79

247.00

ng/l

—

Hypothyroidism, drug reimbursement

145

1.73

2.32

1.0

337.12

308.78

ng/l

0.19

112

Insulin, intermediate and long-acting

182

1426

1.25

2.32

1.0

303.63

323.79

ng/l

0.34

129

990

Benign neoplasm of brain and other parts of central nervous system

133

1.89

2.31

1.1

1.0

312.69

309.49

ng/l

0.02

Carcinoma in situ of skin

202

0.39

2.28

1.1

1.0

398.75

352.28

ng/l

—

126

Aortic aneurysm

623

0.63

2.28

1.0

304.23

315.57

ng/l

0.14

411

Other disorders of penis

200

1.71

2.28

1.1

1.0

376.12

294.98

ng/l

0.77

132

Valvular operations

433

0.55

2.27

1.0

361.63

323.59

ng/l

0.33

288

Other disorders of glucose regulation and pancreatic internal secretion

156

1.80

2.25

1.1

1.0

345.14

289.83

ng/l

0.49

101

Osteoporosis with pathological fracture (FG)

149

1.82

2.24

1.0

288.47

373.18

ng/l

1.16

Osteoporosis

577

1.39

2.24

1.0

314.09

346.06

ng/l

0.50

390

Temporomandibular joint disorders

294

1.57

2.24

1.0

278.63

350.81

ng/l

1.31

225

Hypo-osmolality and hyponatraemia

406

1.48

2.22

1.0

200.30

354.27

ng/l

13.90

270

Impingement syndrome of shoulder

718

1.35

2.21

1.0

296.55

377.56

ng/l

0.78

511

Injuries to the wrist and hand

315

1931

1.18

2.19

1.0

291.25

335.01

ng/l

1.08

247

1362

Other disorders of lacrimal gland

111

840

1.32

2.18

1.0

323.19

374.36

ng/l

0.46

584

Cardiomyopathy (excluding other)

389

0.54

2.18

1.0

253.31

314.19

ng/l

0.55

264

Rheumatism, unspecified

328

1.53

2.18

1.0

323.53

358.10

ng/l

0.33

224

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

718

0.73

2.18

1.0

276.45

303.65

ng/l

0.58

493

Presbyopia

136

1.85

2.18

1.0

351.61

300.57

ng/l

0.24

Acute alcohol intoxication

593

1.39

2.16

1.0

285.07

308.92

ng/l

0.35

417

Non-ischemic cardiomyopathy

721

0.69

2.16

1.0

289.00

357.90

ng/l

1.51

483

Redundant prepuce, phimosis and paraphimosis

392

1.48

2.15

1.0

262.07

284.82

ng/l

0.43

270

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

319

1839

1.18

2.14

1.0

302.46

334.98

ng/l

0.69

237

1310

Hyperparathyroidism

414

1.46

2.14

1.0

281.34

349.20

ng/l

1.63

275

Neuromuscular dysfunction of bladder

189

1.70

2.13

1.1

1.0

250.48

296.01

ng/l

0.63

127

Parodontitis or/and operation codes

206

996

1.23

2.12

1.0

275.68

356.68

ng/l

1.35

149

719

Non-rheumatic valve diseases

126

1183

0.78

2.11

1.0

327.70

333.52

ng/l

0.09

824

Coronary artery bypass grafting

664

0.70

2.08

1.0

283.45

337.27

ng/l

1.40

448

Gout, strict definition

484

0.60

2.08

1.0

271.19

311.04

ng/l

0.55

321

Weight loss

198

1.67

2.08

1.1

1.0

292.18

309.32

ng/l

0.16

127

Subjective visual disturbances

539

1.39

2.07

1.0

403.05

333.07

ng/l

0.38

382

Atrial fibrillation and flutter with reimbursement

590

0.70

2.07

1.0

319.35

352.00

ng/l

0.41

448

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

698

0.74

2.05

1.0

275.18

305.12

ng/l

0.65

484

Fibroblastic disorders

591

1.37

2.05

1.0

294.03

344.04

ng/l

1.29

414

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

473

0.60

2.04

1.1

1.0

330.05

369.68

ng/l

0.29

315

Cardiomyopathies, Primary/intrinsic

380

0.55

2.04

1.0

253.31

312.85

ng/l

0.54

259

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

160

1361

0.80

2.04

1.1

1.0

291.32

331.64

ng/l

1.27

108

948

Intracerebral haemorrhage

262

1.57

2.02

1.0

414.05

335.82

ng/l

0.61

162

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

637

0.66

2.02

1.0

1133.56

348.20

ng/l

0.47

445

Anorexia (incl.atypical)

2.41

2.02

1.1

1.0

186.60

270.61

ng/l

—

Abnormal blood-pressure reading, without diagnosis

1.97

2.00

1.1

1.0

234.82

298.05

ng/l

0.66

Unspecified urinary incontinence

193

1.66

1.99

1.0

307.45

322.61

ng/l

0.12

122

Viral and other specified intestinal infections

227

1.59

1.96

1.1

1.0

287.83

296.41

ng/l

0.08

151

Ocular pain

134

1.80

1.95

1.1

1.0

262.47

308.61

ng/l

0.55

Psoriatic arthropathies

229

0.44

1.95

1.0

222.00

334.07

ng/l

—

165

Primary gonarthrosis, bilateral

130

1437

0.79

1.94

1.0

292.49

360.19

ng/l

1.41

1006

Hypertensive heart and/or renal disease

611

0.70

1.93

1.0

306.68

355.46

ng/l

0.77

409

Other respiratory diseases principally affecting the interstitium

436

0.59

1.93

1.0

300.47

323.81

ng/l

0.16

288

Paracetamol of NSAID medication

154

1.54

1.92

1.0

245.52

374.69

ng/l

3.63

119

Abnormal weight loss

180

1.67

1.91

1.1

1.0

277.00

313.79

ng/l

0.40

113

Renal tubulo-interstitial diseases

279

1818

1.18

1.91

1.0

330.43

337.32

ng/l

0.09

207

1267

Cough

135

1028

1.26

1.89

1.0

327.34

350.44

ng/l

0.40

106

712

Tonsillectomy and adenotomy

669

0.73

1.88

1.0

253.08

298.58

ng/l

1.47

503

Hypertrophic disorders of skin

2.09

1.86

1.0

167.50

299.15

ng/l

—

Hypertensive Heart Disease

562

0.68

1.86

1.0

306.29

364.68

ng/l

0.91

371

Other specific joint derangements/joint disorders

219

1223

1.20

1.85

1.0

287.56

309.82

ng/l

0.76

162

883

Valvular heart disease excluding rheumatic fever

129

1186

0.79

1.85

1.0

329.82

333.24

ng/l

0.05

827

Polycystic ovarian syndrome, consortium definition

187

924

1.22

1.85

1.0

291.52

377.82

ng/l

1.32

131

674

Disorders of sclera, cornea, iris and ciliary body

166

1355

1.23

1.83

1.0

301.84

339.66

ng/l

0.58

123

953

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

145

1233

0.81

1.82

1.1

1.0

302.97

334.42

ng/l

0.84

844

Any reimbursement code in KELA

164

663

1.24

1.81

1.0

263.47

333.45

ng/l

2.56

113

498

Fall involving bed

2.28

1.81

1.1

1.0

239.50

259.73

ng/l

—

Colectomy operation

428

0.61

1.81

1.0

298.41

327.75

ng/l

0.25

287

Other heart diseases

142

749

1.25

1.81

1.0

303.32

330.19

ng/l

0.56

102

576

In situ neoplasms

891

0.73

1.80

1.0

341.11

338.41

ng/l

0.03

602

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

831

0.77

1.80

1.0

654.11

342.58

ng/l

0.43

599

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

831

0.77

1.80

1.0

654.11

342.58

ng/l

0.43

599

Peripheral artery disease

102

1057

0.78

1.79

1.0

318.41

337.88

ng/l

0.30

706

Maternal care related to the fetus and amniotic cavity and possible delivery problems

507

0.72

1.79

1.0

283.32

388.56

ng/l

0.81

394

Gout, unspecified

560

0.66

1.78

1.0

294.63

313.73

ng/l

0.21

369

Pain associated with micturition

255

1.53

1.78

1.0

245.55

312.65

ng/l

1.79

167

Use of pramipexole

530

1.36

1.77

1.0

308.27

337.24

ng/l

0.42

362

Diabetic retinopathy, excluding more controls

328

1.36

1.76

1.0

254.47

297.47

ng/l

0.94

236

Strabismus

521

1.36

1.76

1.0

295.49

323.93

ng/l

0.34

368

Acute alcohol intoxication, ICD10

446

1.39

1.75

1.0

264.60

305.21

ng/l

0.72

316

Bronchitis, not specified as acute or chronic

193

1.61

1.74

1.1

1.0

370.75

310.01

ng/l

0.32

123

Allergic rhinitis

510

1.36

1.73

1.0

302.68

326.26

ng/l

0.35

363

Melanocytic naevi

698

0.70

1.73

1.0

279.40

332.30

ng/l

0.81

482

Benign neoplasm: Colon, unspecified

752

0.71

1.72

1.0

316.36

352.28

ng/l

0.44

497

Pneumonitis due to solids and liquids

155

1.68

1.72

1.0

291.89

301.36

ng/l

0.08

Other postsurgical states

140

1.72

1.71

1.0

148.00

293.78

ng/l

—

Abnormal findings on diagnostic imaging of lung

113

1387

0.79

1.71

1.0

287.84

334.68

ng/l

1.56

931

Hepatocellular carcinoma

0.00

1.71

0.0

1.0

—

304.80

—

Anterior Iridocyclitis

457

1.38

1.70

1.0

313.72

323.50

ng/l

0.12

327

Abnormal findings on diagnostic imaging of other body structures

295

0.54

1.70

1.0

268.70

340.97

ng/l

—

194

Ménière disease

226

1.55

1.70

1.0

303.89

323.65

ng/l

0.18

142

Hemiplegia

1.92

1.70

1.1

1.0

259.33

300.69

ng/l

0.58

Psoriasis vulgaris

457

0.63

1.69

1.0

294.71

317.59

ng/l

0.16

332

Nausea and vomiting

542

1.34

1.69

1.0

324.59

342.60

ng/l

0.20

367

Acute tubulo-interstitial nephritis

194

1437

1.20

1.69

1.1

1.0

327.81

354.89

ng/l

0.33

142

970

Malignant neoplasm of small intestine

0.00

1.69

0.0

1.0

—

285.45

—

Vasomotor and allergic rhinitis

758

1.29

1.68

1.0

283.20

310.44

ng/l

0.59

548

Fall on and from stairs and steps

570

1.34

1.67

1.0

300.27

326.22

ng/l

0.50

403

Asthma and allergy, excluding more controls

185

1.60

1.67

1.1

1.0

283.61

350.98

ng/l

0.92

127

Reimbursement for rheumatic diseases

127

1571

0.81

1.67

1.0

352.21

338.12

ng/l

0.16

1119

Gout, idiopatic and unspecified

681

0.70

1.67

1.0

297.48

312.91

ng/l

0.21

460

Diseases of tongue

134

1.72

1.66

1.0

299.85

353.59

ng/l

0.55

Insulin medication

190

1357

1.20

1.65

1.0

301.53

329.02

ng/l

0.53

135

946

Calcific aortic valvular stenosis, diagnosis (helper)

734

0.72

1.65

1.0

326.25

333.03

ng/l

0.07

463

Operations 2 for CAVS

734

0.72

1.65

1.0

326.25

333.03

ng/l

0.07

463

Calcific aortic valvular stenosis, operated

734

0.72

1.65

1.0

326.25

333.03

ng/l

0.07

463

Calcific aortic valvular stenosis

734

0.72

1.65

1.0

326.25

333.03

ng/l

0.07

463

Other arthrosis

199

1192

1.20

1.65

1.0

296.80

314.91

ng/l

0.45

147

861

Autoimmune diseases excluding thyroid diseases

331

1598

1.15

1.65

1.0

314.43

339.40

ng/l

0.43

252

1154

Benign neoplasm of colon, rectum, anus and anal canal

224

1716

1.18

1.64

1.0

294.58

348.74

ng/l

1.32

163

1187

Early onset COPD

667

0.70

1.64

1.0

338.97

324.21

ng/l

0.10

463

Myocardial infarction, strict

125

1133

0.80

1.64

1.0

320.79

330.96

ng/l

0.16

793

Renal failure

1070

0.78

1.64

1.0

323.99

339.80

ng/l

0.22

716

Hyperlipidaemia, other/unspecified

138

1060

1.23

1.63

1.0

309.41

345.47

ng/l

0.83

106

706

Type 1 diabetes

503

1.35

1.63

1.0

318.78

322.66

ng/l

0.04

354

Alcohol abuse, main dg

335

1.44

1.62

1.0

258.69

307.62

ng/l

0.89

239

Other medical care

1020

0.76

1.62

1.0

925.18

341.36

ng/l

0.56

665

Other disorders of the musculoskeletal system and connective tissue

352

1.42

1.62

1.1

1.0

259.69

329.12

ng/l

1.29

243

Arthrosis

260

1223

1.17

1.61

1.0

322.89

311.52

ng/l

0.15

188

880

Panic disorder

158

1.65

1.61

1.0

206.06

312.05

ng/l

3.96

110

Psoriatic and enteropathic arthropathies

263

0.53

1.60

1.0

254.25

325.59

ng/l

—

191

Other intracranial haemorrhages

2.08

1.60

1.1

1.0

177.80

312.00

ng/l

—

660

0.72

1.59

1.1

1.0

316.21

336.48

ng/l

0.27

422

Asthma and allergy

188

1.58

1.1

1.0

283.61

349.75

ng/l

0.90

130

Carcinoma in situ of skin

173

0.46

1.58

1.1

1.0

398.75

330.17

ng/l

—

105

Acute and subacute iridocyclitis

430

1.37

1.57

1.1

1.0

300.74

323.88

ng/l

0.37

311

ILD medications: immunosuppressive drugs

144

1678

0.82

1.57

1.0

342.26

331.85

ng/l

0.12

109

1210

Abdominal aortic aneurysm (AAA)

233

0.51

1.56

1.0

245.00

317.02

ng/l

—

143

Persons encountering health services in other circumstances

104

822

1.27

1.56

1.0

275.40

334.29

ng/l

2.30

562

Autoimmune diseases excluding thyroid diseases, strict definition

322

1565

1.15

1.56

1.0

320.75

341.43

ng/l

0.32

244

1128

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

144

1161

1.22

1.56

1.0

319.48

346.84

ng/l

0.31

105

840

Malignant melanoma, excluding all cancers (controls excluding all cancers)

495

0.67

1.56

1.0

269.64

336.45

ng/l

0.77

327

Complications of other internal prosthetic devices, implants and grafts

1.89

1.55

1.1

1.0

668.00

312.33

ng/l

—

Calcific aortic valvular stenosis, including rheumatic fever

734

0.73

1.53

1.0

328.00

333.03

ng/l

0.05

463

Benign neoplasm of brain and other parts of central nervous system

153

1.64

1.53

1.1

1.0

312.69

342.38

ng/l

0.17

100

Aneurysms, operations, SAH

390

1.39

1.53

1.0

353.70

338.82

ng/l

0.11

264

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

0.00

1.53

0.0

1.0

—

340.92

—

Allergic asthma (mode)

441

1.36

1.53

1.0

317.23

349.89

ng/l

0.32

309

Dental caries 2 and operation codes, only avohilmo

155

1161

0.83

1.52

1.0

307.01

345.65

ng/l

0.52

106

854

Pneumocystosis

0.00

1.52

0.0

1.0

—

276.12

—

Lesion of sciatic nerve

1.84

1.51

1.0

250.56

307.95

ng/l

—

Crowding of teeth, including avohilmo

0.00

1.51

0.0

1.0

—

251.04

—

Malignant neoplasm of prostate

103

818

0.79

1.51

1.0

318.38

312.61

ng/l

0.06

556

Asthma (mode)

264

1250

1.16

1.51

1.0

290.93

334.01

ng/l

1.73

184

883

Antihypertensive medication - note that there are other indications

149

668

1.22

1.51

1.0

283.72

334.35

ng/l

1.09

521

Autoimmune diseases

356

1600

1.14

1.50

1.0

304.26

339.40

ng/l

0.70

248

1154

Tooth eruption problems

1.87

1.50

1.0

230.30

280.69

ng/l

—

Diaphragmatic hernia

121

980

1.24

1.50

1.0

277.65

343.76

ng/l

1.62

686

Allergic asthma (mode), excluding more controls

443

1.35

1.49

1.0

317.23

348.36

ng/l

0.30

309

Hypertrophic scar

2.01

1.48

1.0

130.29

289.63

ng/l

—

Other noninfective gastroenteritis and colitis

486

1.34

1.48

1.0

250.35

333.55

ng/l

3.68

340

Allergic conjunctivitis

148

1206

1.21

1.48

1.0

321.06

345.74

ng/l

0.28

108

874

Disorders of skin appendages

126

1026

1.23

1.48

1.0

296.76

349.02

ng/l

0.61

736

Myocardial infarction, with ST-elevation

440

0.66

1.46

1.0

412.50

312.07

ng/l

0.62

291

Drug-induced neutropenia

168

0.47

1.46

1.0

414.00

315.90

ng/l

—

109

Other disorders of bladder

276

1.45

1.46

1.0

241.89

320.13

ng/l

1.64

180

Heart failure, not strict

220

1766

0.86

1.46

1.0

300.67

345.84

ng/l

0.96

155

1255

Injuries to the neck

428

1.36

1.45

1.1

1.0

307.83

310.72

ng/l

0.02

308

Endometriosis

443

1.28

1.45

1.0

347.91

335.05

ng/l

0.16

313

Other interstitial pulmonary diseases

378

0.63

1.44

1.0

313.92

327.72

ng/l

0.08

245

Other enthesopathies

770

1.26

1.44

1.0

302.17

370.88

ng/l

0.70

553

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

414

0.65

1.44

1.0

257.78

332.51

ng/l

0.70

269

Interstitial lung disease endpoints

377

0.64

1.43

1.0

313.92

328.27

ng/l

0.08

244

Interstitial lung disease

377

0.64

1.43

1.0

313.92

328.27

ng/l

0.08

244

Disorders of conjunctiva

234

1691

1.16

1.42

1.0

317.74

337.98

ng/l

0.31

171

1206

Benign neoplasm: Sigmoid colon

499

1.33

1.42

1.0

273.36

324.74

ng/l

0.90

341

ILD, hospital admissions

375

0.64

1.40

1.0

313.92

328.27

ng/l

0.08

244

Superficial injury of lower leg

483

1.33

1.40

1.0

297.98

342.36

ng/l

0.68

338

Use of disulfiram, acamprosate or naltrexone

197

1.53

1.40

1.0

242.13

294.28

ng/l

1.01

141

Ascites

178

0.50

1.39

1.0

494.89

316.70

ng/l

—

118

Osteopathies and chondropathies

172

1378

1.18

1.39

1.0

312.60

344.56

ng/l

0.44

117

969

Conjunctivitis

205

1530

1.17

1.39

1.0

312.24

338.23

ng/l

0.38

148

1100

Palmar fascial fibromatosis [Dupuytren]

406

1.36

1.39

1.0

294.33

337.27

ng/l

0.89

278

Coxibs

309

1.31

1.39

1.0

273.84

334.65

ng/l

1.39

219

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

783

0.78

1.39

1.0

322.19

348.10

ng/l

0.39

560

Polyuria

571

1.30

1.39

1.0

338.19

324.79

ng/l

0.17

380

Keratitis

793

1.25

1.38

1.0

286.29

323.25

ng/l

0.72

555

malignant neoplasm of male genital organs

105

826

0.81

1.37

1.0

317.05

312.42

ng/l

0.05

562

Malignant immunoproliferative diseases

2.64

1.37

1.2

1.0

272.83

247.13

ng/l

—

Chronic periodontitis, complicated

249

0.56

1.37

1.1

1.0

372.50

317.15

ng/l

0.31

172

Retinal detachments and breaks

119

974

1.22

1.36

1.0

393.25

328.44

ng/l

0.58

665

Actinic keratosis

986

0.79

1.36

1.0

325.19

352.34

ng/l

0.44

644

Female genital prolapse

439

1.26

1.36

1.0

296.63

336.00

ng/l

0.88

311

Anti-inflammatory and antirheumatic products, non-steroids

310

1.30

1.36

1.0

258.57

334.00

ng/l

2.24

220

Benign neoplasm of other and unspecified endocrine glands

306

1.41

1.35

1.0

255.88

327.86

ng/l

1.51

206

Postpartum haemorrhage

260

0.60

1.35

1.0

452.67

296.18

ng/l

0.76

204

Drug-induced osteoporosis with pathological fracture

0.00

1.35

0.0

1.0

—

293.41

—

Malignant neoplasm of skin

162

1443

0.84

1.34

1.0

295.25

339.54

ng/l

1.35

988

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

285

0.59

1.34

1.0

288.00

331.25

ng/l

0.69

178

Bacterial, viral and other infectious agents

151

1.59

1.34

1.0

282.00

262.85

ng/l

0.12

104

Laparoscopic left hemicolectomy

0.00

1.34

0.0

1.0

—

226.64

—

Assault

191

1.52

1.34

1.0

273.54

281.81

ng/l

0.07

137

Benign neoplasm: Colon

183

1529

1.17

1.34

1.0

287.57

332.32

ng/l

1.72

128

1046

L02BG Aromatase inhibitors

800

0.76

1.34

1.0

333.21

387.96

ng/l

0.46

558

Fentanyl

234

0.55

1.33

1.1

1.0

548.00

346.90

ng/l

—

147

Excessive vomiting in pregnancy

105

1.72

1.33

1.0

291.92

348.84

ng/l

0.59

Oligomenorrhoea

0.00

1.32

0.0

1.0

—

384.40

—

Malignant immunoproliferative diseases

2.53

1.31

1.2

1.0

272.83

256.67

ng/l

—

Disorders of lacrimal system

130

1079

1.21

1.31

1.0

317.14

361.37

ng/l

0.49

742

Glaucoma

191

1438

1.17

1.30

1.0

379.75

326.46

ng/l

0.62

125

986

Vocal cord dysfunction

255

1.42

1.30

1.0

313.55

369.36

ng/l

0.54

188

Other noninflammatory disorders of vagina

129

1.63

1.29

1.0

298.57

386.64

ng/l

0.87

Supplementary factors related to causes of morbidity and mortality classified elsewhere

648

1.27

1.29

1.0

338.13

319.35

ng/l

0.17

453

Papulosquamous disorders

1064

0.80

1.29

1.0

327.60

354.89

ng/l

0.24

758

Type of accident

604

1.28

1.29

1.0

347.86

321.49

ng/l

0.22

421

Disorders of brain, other and unspecified

2.80

1.29

1.0

5341.00

252.00

ng/l

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

449

0.69

1.27

1.0

252.58

339.12

ng/l

3.28

290

Haemorrhage, not elsewhere classified

2.01

1.27

1.1

1.0

362.40

286.44

ng/l

—

Cerebral aneurysm, nonruptured

202

1.49

1.27

1.0

434.71

324.70

ng/l

0.83

134

Cardiac arrhythmias

178

1003

1.17

1.26

1.0

316.06

360.47

ng/l

0.53

127

748

Complications of surgical and medical care, not elsewhere classified

311

1980

1.13

1.26

1.0

434.26

315.55

ng/l

0.49

218

1413

Car occupant injured in other and unspecified transport accidents

336

1.37

1.26

1.1

1.0

286.27

320.85

ng/l

0.38

233

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

758

1.24

1.26

1.0

245.07

336.94

ng/l

3.50

537

Chronic gastritis

758

1.24

1.26

1.0

305.58

334.17

ng/l

0.45

501

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

327

0.64

1.25

1.0

380.46

320.60

ng/l

0.67

201

Insulin, combination of fast acting with intermediate-acting or long-acting

190

1508

1.16

1.25

1.0

301.53

321.61

ng/l

0.36

135

1043

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

115

1.66

1.25

1.0

257.08

326.24

ng/l

0.97

Inflammatory diseases of prostate (prostatitis)

320

1.38

1.24

1.1

1.0

456.92

310.78

ng/l

0.54

219

Viral conjunctivitis

2.41

1.24

1.0

280.83

230.43

ng/l

—

Myocardial infarction

141

1202

0.84

1.24

1.0

313.16

334.83

ng/l

0.42

845

Chronic diseases of tonsils and adenoids

189

1389

0.86

1.24

1.0

311.36

308.59

ng/l

0.05

143

1012

Basal cell carcinoma, including avohilmo

147

1368

0.85

1.24

1.0

292.50

344.47

ng/l

1.75

927

Appendectomy

137

1566

0.84

1.23

1.0

290.74

329.33

ng/l

0.69

105

1118

Small fibre neuropathy

1.92

1.23

1.1

1.0

162.57

333.00

ng/l

—

Leisure time condition

355

1.35

1.23

1.0

339.83

328.89

ng/l

0.05

240

Degenerative macular diseases

287

1.40

1.23

1.0

324.62

312.41

ng/l

0.11

179

Gonarthrosis

242

1213

1.15

1.22

1.0

304.61

312.93

ng/l

0.19

166

872

Myalgia

468

1.31

1.22

1.0

326.93

335.64

ng/l

0.05

335

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

2.66

1.22

1.2

1.0

301.00

267.21

ng/l

—

Other and unspecified injuries of wrist and hand

2.05

1.22

1.1

1.0

209.60

288.37

ng/l

—

Benign mammary dysplasia

313

1.38

1.22

1.0

330.06

352.23

ng/l

0.23

220

Left ventricular outflow tract obstruction (LVOTO), broad definition

252

0.59

1.21

1.0

303.70

310.74

ng/l

—

183

Medicines for HER+ breast cancer

930

0.80

1.21

1.1

1.0

325.95

379.89

ng/l

0.56

655

Inflammatory diseases of female pelvic organs

153

977

1.18

1.20

1.0

303.70

372.59

ng/l

0.94

115

700

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

835

0.80

1.20

1.1

1.0

791.40

326.29

ng/l

0.51

619

Abnormal spermatozoa

348

0.66

1.20

1.0

611.83

307.32

ng/l

0.57

232

Other specified and unspecified retinal disorders

1.84

1.19

1.0

440.38

267.75

ng/l

—

Deviated nasal septum

112

926

1.21

1.19

1.1

1.0

262.49

314.98

ng/l

2.29

656

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

2.31

1.18

1.2

1.0

266.67

257.53

ng/l

—

Dialysis, with operation codes

335

0.66

1.18

1.0

323.47

311.57

ng/l

0.09

237

Radiculopathy

375

1.34

1.18

1.1

1.0

253.41

345.14

ng/l

3.35

269

Myocardial infarction, unclassifiable

476

0.73

1.17

1.0

300.56

321.56

ng/l

0.25

301

Other and unspecified nerve root and plexus disorders, also in other diseases

437

1.31

1.16

1.0

306.78

311.88

ng/l

0.05

305

Pulmonary heart disease, diseases of pulmonary circulation

804

0.78

1.16

1.0

265.20

328.98

ng/l

1.80

548

Functional dyspepsia

623

1.25

1.16

1.0

285.46

338.57

ng/l

1.27

429

Basal cell carcinoma

144

1348

0.85

1.15

1.0

294.03

345.06

ng/l

1.63

913

Primary open-angle glaucoma, strict

685

1.24

1.15

1.0

437.09

333.60

ng/l

0.60

453

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

166

1397

1.16

1.15

1.1

1.0

282.97

315.09

ng/l

1.03

137

1003

Trochanteric bursitis

291

1.38

1.15

1.0

329.10

370.01

ng/l

0.31

202

Other strabismus

402

1.32

1.14

1.0

312.00

323.89

ng/l

0.10

287

Spondylolisthesis/Spondylolysis

412

1.31

1.14

1.0

266.18

349.57

ng/l

2.74

301

Acute nasopharyngitis (common cold)

239

1.42

1.14

1.0

223.36

295.61

ng/l

1.36

178

Fracture of shoulder and upper arm

103

849

1.21

1.14

1.0

277.14

331.84

ng/l

1.17

591

Other/unspecified enthesopathies, not elsewhere classified

199

1.46

1.14

1.0

313.56

354.92

ng/l

0.43

137

Acute renal failure

519

0.73

1.14

1.0

335.18

321.80

ng/l

0.09

340

Iridocyclitis

509

1.28

1.14

1.0

314.53

320.57

ng/l

0.08

362

Cerebral palsy and other paralytic syndromes

224

1.43

1.14

1.0

247.39

312.33

ng/l

1.88

142

Ulcerative proctitis

1.69

1.13

1.0

223.36

294.48

ng/l

0.95

Neuralgia and neuritis, unspecified

103

1.66

1.12

1.0

226.10

328.11

ng/l

—

Other respiratory disorders and diseases

483

0.72

1.12

1.1

1.0

285.67

326.47

ng/l

0.51

316

Other diseases of the respiratory system

483

0.72

1.12

1.1

1.0

285.67

326.47

ng/l

0.51

316

Asthma, excluding more controls

256

1205

1.13

1.12

1.0

284.03

335.62

ng/l

2.43

181

852

Meniscus derangement

203

1211

1.15

1.12

1.0

339.85

312.62

ng/l

0.78

155

874

Follow-up examination after treatment for malignant neoplasms

167

1.50

1.12

1.1

1.0

307.83

366.50

ng/l

0.81

122

Dental caries 2

163

1486

0.86

1.12

1.0

301.98

331.40

ng/l

0.45

113

1084

Enthesopathies of lower limb, excluding foot

493

1.28

1.11

1.0

276.00

407.81

ng/l

1.06

373

Other malignant neoplasms of skin (=non-melanoma skin cancer)

142

1314

0.85

1.11

1.1

1.0

297.00

345.10

ng/l

1.46

891

Tongue abnormality

135

1.56

1.11

1.0

309.91

322.19

ng/l

0.08

L04AX Other immunosuppressants

124

1467

0.84

1.11

1.0

341.40

334.65

ng/l

0.07

1045

Superficial injury of thorax

319

1.35

1.10

1.0

294.12

313.88

ng/l

0.24

220

Benign neoplasms

304

1517

1.12

1.10

1.0

310.20

310.37

ng/l

0.00

226

1068

Oxicams

308

1.28

1.10

1.0

281.02

335.47

ng/l

1.21

218

Second line medication for Crohn's disease

127

1498

0.85

1.10

1.0

337.57

334.77

ng/l

0.03

1063

Benign neoplasm of meninges

226

1.42

1.09

1.0

329.45

324.70

ng/l

0.03

143

Malignant neoplasm of breast, HER-positive

906

0.80

1.09

1.0

324.93

382.07

ng/l

0.59

641

Ischemic heart diseases

300

1681

1.12

1.09

1.0

288.58

348.14

ng/l

1.57

201

1217

Postpartum hemorraghe, parous women as controls

246

0.64

1.09

1.0

452.67

326.08

ng/l

0.56

194

Brachial plexus disorders

152

1.52

1.08

1.0

306.31

286.24

ng/l

0.22

108

Abnormal findings on examination of blood, without diagnosis

149

1195

1.17

1.08

1.0

280.78

323.94

ng/l

1.36

106

819

Diseases of liver

895

0.80

1.08

1.0

336.55

324.82

ng/l

0.11

631

Noninfective enteritis and colitis

126

1065

1.18

1.07

1.0

275.47

351.54

ng/l

1.19

749

Budesonide

295

1.36

1.07

1.0

326.76

325.40

ng/l

0.01

212

DVT of lower extremities

490

0.73

1.07

1.0

361.18

321.65

ng/l

0.33

342

Malignant melanoma

374

0.69

1.07

1.0

292.94

335.18

ng/l

0.31

250

Viral pneumonia

261

1.38

1.07

1.0

233.88

318.38

ng/l

2.11

179

Polypectomy (DHB20)

169

1.48

1.07

1.0

257.75

315.11

ng/l

1.07

111

Ulcer of oesophagus

169

1.48

1.07

1.0

242.08

285.14

ng/l

0.61

103

Other retinal disorders

203

1430

1.14

1.06

1.0

316.37

323.16

ng/l

0.13

139

973

Melanocytic naevi

637

0.77

1.06

1.0

279.40

335.27

ng/l

0.87

451

ILD, hospital admissions 1, main diag only

338

0.68

1.06

1.0

313.92

332.65

ng/l

0.11

217

Dysplasia of cervi uteri

317

0.71

1.06

1.0

318.00

328.06

ng/l

0.07

230

Subarachnoid haemorrhage

253

1.39

1.06

1.0

345.29

324.98

ng/l

0.11

166

Myocardial infarction, without ST-elevation

1037

0.83

1.06

1.0

316.86

334.33

ng/l

0.26

697

Other and unspecified tonsillitis

443

1.26

1.06

1.1

1.0

257.50

299.00

ng/l

0.76

327

Benign neoplasm: Cerebral meninges

211

1.43

1.06

1.0

333.90

331.18

ng/l

0.01

134

Other maltreatment syndromes

2.13

1.05

1.0

312.43

214.45

ng/l

—

Ganglion

462

1.28

1.05

1.0

387.52

412.87

ng/l

0.11

332

Coronary revascularization (ANGIO or CABG)

131

1073

0.85

1.05

1.0

284.67

331.29

ng/l

1.47

750

Nonspecific lymphadenitis

122

0.49

1.05

1.0

269.67

305.71

ng/l

—

Episcleritis

1.67

1.04

1.1

1.0

340.80

302.06

ng/l

—

Dental caries 2, only avohilmo

159

1447

0.87

1.03

1.0

304.17

330.02

ng/l

0.37

109

1052

Deforming dorsopathies

615

1.24

1.03

1.0

258.35

336.73

ng/l

3.55

458

Other diseases of liver

429

0.72

1.03

1.0

298.65

326.03

ng/l

0.20

305

Hypothermia

2.07

1.03

1.0

305.43

245.22

ng/l

—

Artrosis, including avohilmo

287

1410

1.12

1.03

1.0

290.31

340.50

ng/l

1.03

202

1029

Disorders of breast

127

1001

1.18

1.03

1.0

297.32

373.30

ng/l

1.13

717

Benign neoplasm: Colon, unspecified

689

0.78

1.02

1.0

316.36

330.23

ng/l

0.15

464

Acetic acid derivatives and related substances

308

1.25

1.02

1.0

303.74

335.47

ng/l

0.41

218

First line medication for Crohn's disease

295

1789

0.90

1.02

1.0

414.69

310.28

ng/l

0.41

213

1277

Glaucoma suspect

115

972

1.18

1.01

1.0

408.53

320.12

ng/l

0.63

665

Vitamin deficiency, wide

1.69

1.01

1.0

207.67

310.21

ng/l

—

Vitamin deficiency

1.69

1.01

1.0

207.67

310.21

ng/l

—

Major coronary heart disease event excluding revascularizations

193

1515

0.88

1.01

1.0

292.37

325.90

ng/l

1.02

128

1058

Intestinal infectious diseases

271

1890

1.12

1.01

1.0

304.50

336.19

ng/l

0.64

208

1323

Insulin, fast-acting (human)

247

1.38

1.01

1.0

272.20

318.96

ng/l

0.84

168

DVT of lower extremities and pulmonary embolism

1102

0.83

1.01

1.0

295.89

333.21

ng/l

0.77

753

Nasal polyp

510

1.26

1.00

1.0

299.86

317.07

ng/l

0.25

353

Dental caries 2 and operation codes

160

1461

0.87

1.00

1.0

303.50

331.09

ng/l

0.41

111

1066

Disorders of refraction and accommodation

473

1.26

0.99

1.0

344.22

322.57

ng/l

0.19

341

Diabetic neuropathy

221

1.40

0.99

1.1

1.0

282.10

273.65

ng/l

0.08

156

Type 1 diabetes, wide definition, subgroup 1

395

1.29

0.99

1.0

328.36

318.76

ng/l

0.09

282

Viral hepatitis

115

1.57

0.99

1.1

1.0

216.82

251.24

ng/l

0.54

Sequelae of injuries of upper limb

214

1.40

0.99

1.1

1.0

286.83

314.20

ng/l

0.33

144

Use of antiglaucoma preparations and miotics

164

1.47

0.99

1.0

295.53

315.64

ng/l

0.19

103

Pain and other conditions associated with female genital organs and menstrual cycle

279

1.34

0.98

1.1

1.0

297.73

332.94

ng/l

0.43

203

1058

0.83

0.98

1.0

321.42

348.80

ng/l

0.49

690

Dermatophytosis

332

0.69

0.98

1.0

229.65

311.63

ng/l

2.28

229

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

390

0.72

0.98

1.0

399.42

336.17

ng/l

0.30

249

Carcinoma in situ of skin of ear and external auricular canal

0.00

0.98

0.0

1.0

—

351.00

—

Portal vein thrombosis

0.00

0.98

0.0

1.0

—

228.64

—

Inflammation of lacrimal passages (acute and unspecified)

0.00

0.98

0.0

1.0

—

326.31

—

Chronic kidney disease

714

0.79

0.97

1.0

304.60

324.75

ng/l

0.30

467

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.00

0.97

0.0

1.0

—

277.67

—

Universal erythroderma, KELA reimbursement

0.00

0.97

0.0

1.0

—

235.53

—

Ulcer of lower limb, not elsewhere classified

331

0.69

0.97

1.0

335.83

318.20

ng/l

0.11

218

Disorder of lipoprotein metabolism, unspecified

362

1.30

0.97

1.0

317.18

341.76

ng/l

0.25

237

Diseases of arteries, arterioles and capillaries

179

1520

0.88

0.97

1.0

304.21

327.42

ng/l

0.64

126

1033

Emergency coronary revascularization (for ACS)

148

1226

0.87

0.96

1.0

282.26

328.08

ng/l

1.62

841

Other follicular disorders

116

1.56

0.96

1.0

329.92

289.51

ng/l

0.32

Visual impairment including blindness (binocular or monocular)

108

1.58

0.96

1.0

382.50

318.85

ng/l

0.39

Paralytic strabismus

157

1.47

0.96

1.0

211.08

316.45

ng/l

1.63

Ischaemic heart disease, wide definition

297

1678

1.11

0.96

1.0

289.07

348.84

ng/l

1.57

200

1211

Secondary malignant neoplasm of other and unspecified sites

0.00

0.95

0.0

1.0

—

298.72

—

Neuroendocrine tumor and carcinoma of small intestine

0.00

0.95

0.0

1.0

—

243.89

—

1.69

0.94

1.0

323.71

358.30

ng/l

—

Asthma mixed form (mode)

117

0.51

0.94

1.0

545.50

358.58

ng/l

—

Nephropathy related operations

305

0.69

0.94

1.0

298.33

304.20

ng/l

0.04

214

Asthma mixed form (mode), excluding more controls

119

0.50

0.93

1.0

545.50

358.90

ng/l

—

malignant neoplasm of female genital organs

328

0.70

0.93

1.1

1.0

271.87

361.33

ng/l

1.62

227

Coxarthrosis, primary, with hip surgery

119

1315

0.86

0.93

1.0

371.85

336.15

ng/l

0.21

892

Appendicitis, broad definition

178

1844

0.88

0.93

1.1

1.0

280.19

331.56

ng/l

1.39

139

1330

Thyrotoxicosis with diffuse goitre

269

0.67

0.93

1.0

269.83

342.86

ng/l

0.54

190

Panniculitis affecting regions of neck and back

1.72

0.92

1.1

1.0

202.83

320.02

ng/l

—

Early onset COPD, excluding more controls

600

0.78

0.92

1.0

338.97

348.32

ng/l

0.06

415

Irregular menses

105

720

1.18

0.92

1.0

248.87

382.78

ng/l

1.88

534

Dental caries 3 and operation codes, only avohilmo

388

1.21

0.92

1.0

302.16

331.31

ng/l

0.45

278

Benign neoplasm of colon, rectum, anus and anal canal

214

1361

1.12

0.91

1.0

293.46

328.92

ng/l

1.31

155

954

Gonarthrosis, primary, with knee surgery

165

1533

0.88

0.91

1.0

336.91

355.81

ng/l

0.25

1077

Asthma

259

1248

1.11

0.91

1.0

289.26

334.24

ng/l

1.84

184

882

Primary_lymphoid and hematopoietic malignant neoplasms

687

0.80

0.90

1.1

1.0

343.19

343.46

ng/l

0.00

466

Retinal detachment with retinal break

340

1.30

0.90

1.1

1.0

519.94

311.63

ng/l

0.85

229

Enlarged lymph nodes

314

1.31

0.89

1.0

283.42

332.27

ng/l

1.16

232

Diseases of pulp and periapical tissues, including avohilmo

338

1600

1.10

0.89

1.0

330.49

314.13

ng/l

0.29

243

1122

Benign neoplasm: Stomach

236

1.36

0.89

1.1

1.0

380.86

334.81

ng/l

0.32

148

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

546

1.23

0.89

1.0

317.12

311.88

ng/l

0.05

393

Corneal ulcer

376

1.28

0.89

1.0

230.50

314.07

ng/l

2.25

269

Dental pulpitis 1

338

1601

1.10

0.89

1.0

329.75

314.13

ng/l

0.28

243

1123

Dental pulpitis 4

338

1601

1.10

0.88

1.0

329.75

314.13

ng/l

0.28

243

1123

Tinnitus

593

1.22

0.87

1.0

301.06

337.43

ng/l

0.57

425

Gout, FINNGEN

815

0.82

0.87

1.0

279.16

322.16

ng/l

1.01

542

Seropositive rheumatoid arthritis, strict definition

369

0.73

0.87

1.0

358.77

338.50

ng/l

0.16

249

Mouth breathing

127

1099

1.16

0.87

1.0

264.15

314.19

ng/l

2.01

783

Soft tissue disorders related to use, overuse and pressure

694

1.20

0.86

1.0

293.98

385.89

ng/l

0.88

493

Divergent concomitant strabismus

136

1.47

0.86

1.1

1.0

282.42

300.14

ng/l

0.12

Diseases of appendix

181

1855

0.89

0.86

1.0

283.08

331.76

ng/l

1.30

142

1337

Other diseases of upper respiratory tract

359

1715

1.09

0.86

1.0

303.84

320.59

ng/l

0.55

258

1208

Other/unspecified seropositive rheumatoid arthritis

704

0.81

0.86

1.0

344.24

340.35

ng/l

0.04

483

Pulmonary embolism

736

0.81

0.85

1.1

1.0

255.51

330.77

ng/l

2.35

508

Pulmonary heart disease

735

0.82

0.84

1.0

255.51

330.19

ng/l

2.32

507

Seropositive rheumatoid arthritis, wide

713

0.81

0.84

1.0

340.53

338.92

ng/l

0.02

489

Nummular dermatitis

196

1.38

0.84

1.0

253.05

320.05

ng/l

1.25

132

Adjustment and management of implanted device

446

0.76

0.84

1.0

304.93

325.65

ng/l

0.32

277

Achilles tendinitis

239

1.34

0.84

1.0

308.52

337.30

ng/l

0.24

182

Other symptoms and signs involving the circulatory and respiratory systems

137

1.46

0.84

1.0

322.93

317.81

ng/l

0.02

Fitting and adjustment of other devices

111

888

1.16

0.83

1.0

379.20

342.89

ng/l

0.59

577

Conduction disorders

756

0.83

1.0

275.55

352.48

ng/l

3.00

507

Malignant melanoma of skin

285

0.70

0.83

1.0

283.69

315.93

ng/l

0.17

190

Dental pulpitis 4, only avohilmo

343

1641

1.09

0.82

1.0

327.50

312.87

ng/l

0.25

242

1156

Skin changes due to chronic exposure to nonionizing radiation

1002

0.85

0.82

1.0

325.15

350.59

ng/l

0.42

658

Malignant neoplasm of breast

118

983

0.87

0.82

1.0

613.52

336.57

ng/l

0.46

704

Benign neoplasm: Sigmoid colon

543

1.22

0.82

1.0

273.36

336.26

ng/l

1.20

360

Haemorrhage from respiratory passages

109

870

1.16

0.82

1.0

297.10

351.24

ng/l

1.25

586

Dissociative [conversion] disorders

1.88

0.82

1.0

190.17

307.00

ng/l

—

Speech therapy

662

1.19

0.81

1.0

324.17

331.02

ng/l

0.04

453

Nonsuppurative otitis media

266

0.71

0.81

1.0

360.00

324.36

ng/l

0.21

175

Other pleural conditions

237

0.67

0.81

1.1

1.0

571.20

314.40

ng/l

—

144

Atypical facial pain

1.55

0.81

1.0

314.13

313.70

ng/l

—

Other abnormal findings of blood chemistry

1.58

0.81

1.0

173.00

311.10

ng/l

—

Other diseases of blood and blood-forming organs, wide

544

0.79

0.81

1.0

321.97

333.79

ng/l

0.13

384

Asthma (diagnoses ohter than nonallergic)

249

1931

1.10

0.81

1.0

296.37

338.84

ng/l

0.98

180

1365

Acute appendicitis, with complications

499

0.78

0.80

1.1

1.0

327.17

318.25

ng/l

0.09

350

Hydrocele

267

1.31

0.80

1.0

265.35

303.31

ng/l

0.51

174

Other and unspecified effects of external causes

499

1.22

0.80

1.0

314.44

321.79

ng/l

0.08

357

Heterophoria

122

1.48

0.80

1.0

249.89

297.12

ng/l

—

Carcinoid syndrome

0.00

0.79

0.0

1.0

—

253.36

—

Sub-endpoint used in defining T1D endpoints

572

1.20

0.79

1.0

313.72

308.95

ng/l

0.05

398

Other and unspecified haemorrhagic conditions

0.00

0.79

0.0

1.0

—

247.13

—

Varus deformity, not elsewhere classified

0.00

0.79

0.0

1.0

—

407.69

—

Malignant neoplasm of heart, mediastinum and pleura

0.00

0.79

0.0

1.0

—

260.62

—

Type 1 diabetes, wide definition, subgroup 2

0.00

0.79

0.0

1.0

—

237.92

—

COPD/asthma/ILD related infections

342

1573

1.09

0.79

1.0

268.08

356.97

ng/l

2.97

243

1123

COPD/asthma related infections

342

1573

1.09

0.79

1.0

268.08

356.97

ng/l

2.97

243

1123

Other joint disorders

255

1231

1.10

0.79

1.0

307.84

310.33

ng/l

0.05

185

886

Dental pulpitis 1, only avohilmo

343

1646

1.09

0.79

1.0

326.53

312.67

ng/l

0.24

240

1161

Collagenous colitis

190

1.37

0.79

1.0

286.84

323.70

ng/l

0.42

125

Non-follicular lymphoma, hilmo, excluding all cancers

270

0.70

0.78

1.0

321.14

337.33

ng/l

0.13

173

Seropositive rheumatoid arthritis

705

0.82

0.78

1.0

340.53

326.43

ng/l

0.17

476

Acquired absence of organs, not elsewhere classified

0.00

0.78

0.0

1.0

—

266.33

—

Other disorders of veins

1095

0.86

0.78

1.0

407.03

348.67

ng/l

0.33

797

Familial hypercholesterolemia

429

1.24

0.78

1.0

271.66

350.67

ng/l

1.55

281

ILD medications

305

1826

0.92

0.78

1.0

295.47

329.30

ng/l

0.77

215

1305

Melanoma of uvea

0.00

0.77

0.0

1.0

—

282.15

—

Other hammer toe(s) (acquired)

465

0.79

0.77

1.1

1.0

367.27

344.01

ng/l

0.17

315

Endometriosis of rectovaginal septum and vagina

140

1.43

0.76

1.1

1.0

365.73

396.48

ng/l

0.14

Abnormalities of heart beat

844

1.16

0.76

1.0

267.68

346.13

ng/l

3.45

572

Asthma (only as main-diagnosis), excluding more controls

224

1205

1.11

0.76

1.0

309.03

335.62

ng/l

0.66

152

852

Pulmonary eosinophilia, not elsewhere classified

0.00

0.76

0.0

1.0

—

280.58

—

Other interventions on the root canals of the tooth

0.00

0.76

0.0

1.0

—

272.61

—

Injuries to the knee and lower leg

361

1908

1.08

0.76

1.0

295.25

338.00

ng/l

1.01

263

1347

Mycoses

627

0.81

0.76

1.0

276.03

326.88

ng/l

1.37

437

Persons encountering health services for specific procedures, not carried out

132

1.44

0.76

1.0

236.92

321.36

ng/l

1.10

L02BA Anti-estrogens

359

0.75

1.1

1.0

298.80

368.37

ng/l

1.02

246

Other and unspecified urticaria

377

1.25

0.75

1.0

256.41

337.82

ng/l

2.17

259

Carpal tunnel syndrome

190

1542

1.11

0.75

1.0

306.53

339.22

ng/l

0.56

140

1098

Atopic dermatitis, strict definition

387

1.24

0.75

1.0

261.17

315.03

ng/l

1.33

277

Antenatal screening

165

0.72

0.75

1.0

245.31

280.79

ng/l

0.73

140

Gonarthrosis [arthrosis of knee](FG)

283

1524

1.09

0.75

1.0

306.39

336.60

ng/l

0.54

200

1093

Other protozoal intestinal diseases

2.09

0.74

1.2

1.0

401.00

225.69

ng/l

—

Malignant neoplasm of breast, HER2-negative

116

976

0.87

0.74

1.0

624.10

337.28

ng/l

0.47

699

Asthma, hospital admissions , main diagnosis only

232

1888

1.10

0.74

1.0

306.20

338.67

ng/l

0.62

157

1349

Polymyalgia rheumatica

324

0.74

1.0

374.17

324.71

ng/l

0.40

209

L02BB Anti-androgens

220

0.68

0.74

1.0

356.63

317.24

ng/l

—

141

Benign neoplasm of other and unspecified endocrine glands

342

1.26

0.74

1.0

255.88

339.18

ng/l

1.91

230

Pedal cyclist injured in transport accident

450

1.22

0.74

1.0

275.23

319.88

ng/l

0.77

319

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

690

0.83

0.74

1.0

344.24

341.47

ng/l

0.03

476

Venous thromboembolism

134

1471

0.88

0.73

1.0

299.90

323.80

ng/l

0.52

1015

Dentofacial anomalies [including malocclusion]

581

1.19

0.73

1.0

299.38

328.05

ng/l

0.57

424

Lateral epicondylitis

307

1.27

0.73

1.0

307.33

351.36

ng/l

0.39

224

Urticaria

588

1.19

0.72

1.0

285.55

332.82

ng/l

1.02

424

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

311

0.74

0.72

1.0

287.31

346.27

ng/l

0.90

193

Sulfonylureas

852

0.86

0.72

1.1

1.0

344.65

353.72

ng/l

0.07

571

Type 1 diabetes, wide definition

415

1.23

0.72

1.0

328.36

317.87

ng/l

0.10

289

Primary open-angle glaucoma

826

1.16

0.72

1.0

416.03

332.09

ng/l

0.55

549

Coronary angioplasty

105

926

0.87

0.72

1.0

290.36

336.37

ng/l

1.07

645

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

172

1773

0.90

0.72

1.0

281.19

346.46

ng/l

1.59

136

1218

Insulin, fast-acting

848

1.16

0.71

1.0

352.96

315.42

ng/l

0.46

596

Dental caries 1 and operation codes, only avohilmo

349

1.18

0.71

1.0

303.49

336.85

ng/l

0.47

249

Noninfectious colitis NAS

264

1.29

0.71

1.0

221.50

334.28

ng/l

5.99

177

UC patients in KELA-register (code 208), prior to 1994

109

1.47

0.71

1.1

1.0

479.20

284.50

ng/l

—

Alcoholic gastritis

1.93

0.71

1.2

1.0

303.60

230.86

ng/l

—

Infections of the skin and subcutaneous tissue

152

1351

1.12

0.70

1.0

287.25

308.88

ng/l

0.52

110

961

Iron deficiency anaemia secondary to blood loss (chronic)

365

0.77

0.69

1.0

345.00

325.31

ng/l

0.12

240

Herpesviral [herpes simplex] infections

228

0.70

0.69

1.0

251.00

332.53

ng/l

—

155

Otalgia

135

1.41

0.69

1.0

243.57

301.14

ng/l

0.72

Melanoma in situ of other and unspecified parts of face

1.86

0.68

1.0

217.00

251.69

ng/l

—

Chronic lower respiratory diseases

372

1870

1.08

0.68

1.0

284.84

338.67

ng/l

1.62

265

1333

Acute pharyngitis

220

1.31

0.68

1.0

302.25

304.04

ng/l

0.01

155

Maltreatment syndromes

1.67

0.68

1.1

1.0

360.57

232.19

ng/l

—

Lyme disease

648

1.17

0.68

1.1

1.0

313.93

341.33

ng/l

0.45

453

Varicose veins

180

1505

0.90

0.68

1.0

329.49

348.73

ng/l

0.29

118

1074

Asthma (only as main-diagnosis)

227

1248

1.10

0.68

1.0

308.75

334.24

ng/l

0.63

153

882

Diseases of the skin and subcutaneous tissue

331

1536

1.08

0.68

1.0

301.30

345.34

ng/l

0.91

227

1095

Insulin, fast-acting or short human

862

1.15

0.67

1.0

350.57

313.18

ng/l

0.46

599

Crohn's disease NAS

102

1.47

0.67

1.0

350.20

270.51

ng/l

0.36

Polyarthrosis

551

1.18

0.67

1.0

329.62

339.64

ng/l

0.07

381

Other menopausal disorders

420

0.84

0.67

1.0

326.49

335.70

ng/l

0.11

302

Ovarian cyst

443

1.16

0.66

1.0

694.00

335.05

ng/l

0.45

313

Other disorders of bone

411

1.22

0.66

1.0

268.10

323.17

ng/l

1.42

296

Diseases of middle ear and mastoid

902

0.87

0.66

1.0

304.00

316.13

ng/l

0.19

633

Postpartum hemorraghe, all women as controls

248

0.72

0.66

1.0

452.67

303.47

ng/l

0.72

195

Alcohol abuse counselling and surveillance

1.79

0.66

1.2

1.0

193.80

232.38

ng/l

—

Fracture of lower leg, including ankle

163

1462

1.11

0.66

1.0

291.32

343.82

ng/l

0.96

112

1032

Injuries to the hip and thigh

130

1057

1.13

0.66

1.0

324.74

332.02

ng/l

0.10

727

Rheumatoid arthritis, including avohilmo

1035

0.87

0.66

1.0

325.45

327.02

ng/l

0.02

709

Other peripheral vascular diseases

171

1.35

0.65

1.0

332.00

307.42

ng/l

0.19

106

Special screening examination for neoplasms

1.62

0.65

1.2

1.0

376.00

366.28

ng/l

—

Female infertility, cervigal, vaginal, other or unspecified origin

354

0.81

0.65

1.0

271.21

334.25

ng/l

1.40

260

Cellulitis

495

1.19

0.64

1.0

317.07

323.83

ng/l

0.07

347

Benign neoplasm: Rectum

486

1.20

0.64

1.0

317.79

333.82

ng/l

0.25

333

Other (seronegative) rheumatoid arthritis, wide

460

0.80

0.64

1.0

349.24

334.79

ng/l

0.13

319

Melanoma in situ of other and unspecified parts of face

1.73

0.64

1.0

217.00

248.00

ng/l

—

Benign neoplasm of meninges

251

1.28

0.64

1.0

329.45

343.37

ng/l

0.08

163

Temporomandibular joint disorders, including avohilmo

763

1.15

0.64

1.0

268.05

370.29

ng/l

1.35

559

Other and unspecified visual disturbances

198

1.32

0.64

1.0

517.26

319.33

ng/l

0.35

129

COPD differential diagnosis

271

1250

1.09

0.64

1.0

293.61

334.01

ng/l

1.65

205

883

ILD differential diagnosis

271

1250

1.09

0.63

1.0

293.61

334.01

ng/l

1.65

205

883

Other spirochaetal diseases

653

1.16

0.63

1.1

1.0

313.93

340.77

ng/l

0.44

455

L04AA Selective immunosuppressants

492

0.81

0.63

1.0

386.81

327.76

ng/l

0.61

353

Haemorrhage in early pregnancy

466

1.19

0.63

1.1

1.0

391.61

337.60

ng/l

0.68

343

Gastroduodenal ulcer

652

1.16

0.63

1.0

318.96

330.56

ng/l

0.15

437

Chronic ulcer of skin, not elsewhere classified

153

0.65

0.62

1.1

1.0

298.20

319.72

ng/l

—

Polyarthropathies

201

1221

1.10

0.62

1.0

330.23

311.77

ng/l

0.21

143

878

Inflammatory bowel disease

682

1.16

0.62

1.0

289.95

314.88

ng/l

0.39

494

Hypoparathyroidism

1.55

0.62

1.0

187.20

335.36

ng/l

—

Viral warts

176

0.68

0.61

1.0

349.71

308.16

ng/l

—

115

Corneal degeneration

1.67

0.61

1.0

351.00

276.32

ng/l

—

Corns and callosities

147

1.36

0.61

1.1

1.0

332.40

303.78

ng/l

—

Coagulation defects, purpura and other haemorrhagic conditions

391

0.79

0.61

1.0

321.21

323.95

ng/l

0.02

265

Malignant neoplasm of head and neck

199

0.70

0.61

1.0

288.11

312.87

ng/l

—

131

Systemic connective tissue disorders

868

0.86

0.61

1.0

351.96

335.52

ng/l

0.21

588

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.0

—

292.36

—

Cardiomyopathies, Secondary/extrinsic

0.00

0.60

0.0

1.0

—

257.90

—

Bell's palsy

271

1.26

0.60

1.0

311.28

323.59

ng/l

0.14

188

Carcinoma in situ of breast, lobular

0.00

0.60

0.0

1.0

—

386.40

—

Other congenital malformations of upper alimentary tract

0.00

0.60

0.0

1.0

—

258.70

—

Other and unspecified aplastic anaemias

0.00

0.60

0.0

1.0

—

263.80

—

Unspecified haematuria

129

988

1.12

0.60

1.0

331.86

326.47

ng/l

0.08

674

Tooth agenesis EXCLUDE clefts and syndromes

0.00

0.60

0.0

1.0

—

244.15

—

Ductal carcinoma of pancreas

0.00

0.60

0.0

1.0

—

261.80

—

Postprocedural musculoskeletal disorders, not elsewhere classified

165

1.34

0.60

1.1

1.0

211.64

309.66

ng/l

2.35

105

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.0

—

280.47

—

Malignant neoplasm of breast, HER-negative

510

0.82

0.60

1.0

1192.53

359.22

ng/l

0.47

347

IBD patients in KELA-register

453

1.19

0.60

1.0

314.71

313.07

ng/l

0.01

328

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.0

—

241.06

—

Dentinal caries

515

1.18

0.60

1.0

836.51

332.69

ng/l

0.49

361

Toxic effects of substances chiefly nonmedicinal as to source

218

1.29

0.60

1.0

291.14

327.31

ng/l

0.40

147

Arthropathies

262

1231

1.08

0.59

1.0

297.01

310.33

ng/l

0.39

191

886

Injury of muscle and tendon at lower leg level

378

0.79

0.59

1.0

263.82

313.20

ng/l

0.81

264

Benign neoplasm: Cerebral meninges

236

1.27

0.59

1.0

333.90

353.54

ng/l

0.11

153

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.59

0.0

1.0

—

289.69

—

Benign neoplasm: Short bones of lower limb

0.00

0.59

0.0

1.0

—

294.06

—

Carcinoma in situ of skin of ear and external auricular canal

0.00

0.59

0.0

1.0

—

335.08

—

Benign neoplasm: Adrenal gland

192

1.30

0.59

1.0

309.59

315.70

ng/l

0.05

122

Female infertility

363

0.83

0.59

1.0

266.24

333.89

ng/l

1.70

266

ILD, hospital admission 2, with pulmonary infections

220

0.73

0.58

1.0

289.88

347.87

ng/l

—

144

Pilonidal cyst

114

1.41

0.58

1.0

229.40

267.77

ng/l

—

Adhesive capsulitis of shoulder

427

1.20

0.58

1.0

353.44

353.68

ng/l

0.00

307

Melanoma of uvea

0.00

0.58

0.0

1.0

—

293.08

—

Combined immunodeficiencies

0.00

0.58

0.0

1.0

—

245.08

—

Other diseases of oesophagus

210

1.29

0.58

1.0

247.16

303.99

ng/l

0.67

131

Dissocial personality disorder

0.00

0.58

0.0

1.0

—

222.69

—

Accidental poisoning by and exposure to alcohol

0.00

0.58

0.0

1.0

—

251.08

—

Spirochaetal infections, other/unspecified

193

1.30

0.57

1.1

1.0

268.74

329.77

ng/l

0.93

124

Polyarthritis, unspecified

1.49

0.57

1.0

232.00

290.12

ng/l

—

Inflammatory bowel disease, strict (require KELA)

456

1.19

0.57

1.0

314.71

310.61

ng/l

0.04

334

Benign neoplasms

226

1178

1.09

0.56

1.0

305.76

310.60

ng/l

0.09

170

833

Benign neoplasm: Skin of upper limb, including shoulder

1.63

0.55

1.0

357.33

322.17

ng/l

—

Benign neoplasm: Skin of upper limb, including shoulder

1.63

0.55

1.0

357.33

243.88

ng/l

—

Burns and corrosions

274

0.77

0.55

1.1

1.0

287.79

303.93

ng/l

0.09

188

Myeloproliferative diseases

206

0.73

0.55

1.0

277.30

322.69

ng/l

—

134

Prepatellar bursitis

107

1.41

0.55

1.0

259.00

345.83

ng/l

—

Other and unspecified vascular occlusions

212

1.28

0.55

1.0

295.06

303.04

ng/l

0.06

132

Cholelithiasis, broad definition with cholecystitis

245

1809

0.93

0.55

1.0

317.82

340.82

ng/l

0.41

158

1289

Covid-19 suspected case

339

1.21

0.54

1.0

303.00

318.37

ng/l

0.16

240

Other viral diseases

485

1.17

0.54

1.0

308.63

302.58

ng/l

0.05

353

Fracture of femur

537

1.16

0.54

1.1

1.0

324.92

337.27

ng/l

0.12

350

Stenosis and insufficiency of lacrimal passages

186

1.29

0.54

1.1

1.0

301.92

343.88

ng/l

0.65

121

Peripheral artery operations in Hilmo

306

0.78

0.54

1.0

285.00

321.40

ng/l

0.28

189

Bronchitis

280

1967

0.93

0.53

1.0

254.92

344.27

ng/l

3.80

200

1392

Other disorders of breast

231

1.26

0.53

1.1

1.0

275.59

359.18

ng/l

0.92

166

Scleritis and episcleritis

108

1.39

0.53

1.1

1.0

340.80

299.25

ng/l

—

Misadventures to patients during surgical and medical care

322

1.21

0.53

1.0

1107.94

323.96

ng/l

0.45

216

Ankylosing spondylitis

178

1.29

0.53

1.0

282.20

324.41

ng/l

0.55

131

Injury of muscle and tendon at wrist and hand level

304

1.22

0.52

1.0

252.55

309.12

ng/l

1.06

219

Other pulmonary diagnosis

270

1259

1.07

0.52

1.0

294.29

333.93

ng/l

1.59

202

887

Unspecified misadventure during surgical and medical care

117

1.37

0.52

1.0

233.73

298.38

ng/l

0.75

Overexertion and strenuous or repetitive movements

214

1.26

0.52

1.0

235.36

318.36

ng/l

1.70

141

Allergic contact dermatitis

259

1.24

0.52

1.0

370.12

342.53

ng/l

0.20

178

Diagnoses used for exclusion with ILD

629

1.15

0.51

1.0

292.80

320.25

ng/l

0.59

429

Idiopathic gout

237

0.76

0.51

1.0

284.09

315.52

ng/l

0.38

153

Acne vulgaris

1.50

0.51

1.2

1.0

201.67

211.63

ng/l

—

Fenamates

223

1.21

0.51

1.0

381.78

335.77

ng/l

0.36

155

Conjunctivitis (acute, non atopic)

534

1.16

0.51

1.0

291.35

316.32

ng/l

0.27

378

Ulcerative rectosigmoiditis

170

1.30

0.51

1.0

310.94

312.34

ng/l

0.01

115

Chronic rhinitis, nasopharyngitis and pharyngitis

761

1.13

0.51

1.0

768.41

321.45

ng/l

0.49

542

Primary_lymphoid and hematopoietic malignant neoplasms

640

0.86

0.51

1.1

1.0

343.19

321.91

ng/l

0.15

429

Benign neoplasm of major salivary glands

259

0.77

0.51

1.1

1.0

353.17

333.40

ng/l

0.10

167

Gastric ulcer

434

1.18

0.51

1.0

309.65

333.70

ng/l

0.26

280

Aplastic and other anaemias

105

1109

0.90

0.51

1.0

334.06

347.50

ng/l

0.18

738

Entropion and trichiasis of eyelid

191

0.73

0.50

1.1

1.0

290.25

322.86

ng/l

—

114

Complications of procedures, not elsewhere classified

240

1931

1.07

0.50

1.0

478.12

315.81

ng/l

0.55

172

1374

Presence of cardiac and vascular implants and grafts

128

1068

0.91

0.50

1.0

279.07

325.83

ng/l

1.84

721

Diseases of pulp and periapical tissues

926

0.89

0.50

1.0

670.94

316.40

ng/l

0.46

664

Other disorders of bone density and structure

1.47

0.50

1.2

1.0

383.00

263.32

ng/l

—

Lung diseases due to external agents

297

1.21

0.50

1.0

269.25

320.97

ng/l

0.83

195

Gestational diabetes (for exclusion)

246

0.81

0.50

1.0

252.00

307.20

ng/l

1.03

194

Abnormal serum enzyme levels

875

1.12

0.49

1.0

307.45

321.06

ng/l

0.20

598

461

0.84

0.49

1.0

353.12

333.77

ng/l

0.21

288

All influenza (not pneumonia)

316

1.20

0.49

1.1

1.0

202.79

322.70

ng/l

5.53

219

Non-follicular lymphoma

246

0.77

0.49

1.0

321.14

312.74

ng/l

0.06

163

Benign neoplasm of eye and adnexa

246

0.77

0.49

1.0

312.36

350.43

ng/l

0.30

159

Hydronephrosis

257

0.78

0.49

1.0

340.64

311.77

ng/l

0.25

165

Deep endometriosis

154

1.30

0.48

1.1

1.0

365.73

341.06

ng/l

0.11

101

Other specified and unspecified personality disorders

154

1.30

0.48

1.1

1.0

192.67

288.13

ng/l

2.56

102

Non-allergic asthma (mode)

488

1.16

0.48

1.0

304.56

356.06

ng/l

0.71

332

Exposure to other specified factors

202

1758

1.08

0.48

1.0

472.75

307.62

ng/l

0.50

158

1250

Benign neoplasm of major salivary glands

256

0.78

0.48

1.1

1.0

353.17

322.86

ng/l

0.17

172

Other infective otitis externa

128

1.33

0.47

1.0

294.25

305.64

ng/l

0.09

Non-allergic asthma (mode), excluding more controls

489

1.16

0.47

1.0

304.56

358.84

ng/l

0.77

329

Varicose veins of other sites

146

1.30

0.47

1.0

231.77

308.29

ng/l

0.97

Cholelithiasis

236

1771

0.93

0.47

1.0

316.57

343.11

ng/l

0.48

155

1258

ILD, hospital admissions 3, with pneumonia sepsis

188

0.74

0.46

1.0

281.17

328.21

ng/l

—

120

Dislocation, sprain and strain of joints and ligaments at neck level

245

1.23

0.46

1.0

252.55

321.64

ng/l

1.09

170

Gout

694

0.88

0.46

1.0

279.16

324.89

ng/l

1.10

480

Personal history of other diseases and conditions

128

1.32

0.46

1.0

258.92

305.36

ng/l

0.48

Acute appendicitis

172

1754

0.92

0.46

1.1

1.0

282.96

330.10

ng/l

1.16

134

1271

Lesion of ulnar nerve

337

1.19

0.46

1.0

295.19

311.56

ng/l

0.10

243

Spondylopathies (FG)

282

1.21

0.46

1.0

269.05

314.39

ng/l

0.89

205

Other/unspecified enthesopathies of lower limb, excluding foot

129

1.32

0.45

1.0

244.09

346.38

ng/l

0.83

Excluding asthma or asthma-COPD overlap

268

1259

1.07

0.45

1.0

294.23

333.93

ng/l

1.60

202

887

Preterm labour and delivery

534

1.14

0.44

1.0

295.02

379.41

ng/l

0.61

396

Outcome of delivery

0.70

0.44

1.0

181.30

276.07

ng/l

—

Other diseases of intestine

311

1.19

0.44

1.0

300.39

320.71

ng/l

0.22

217

Dermatitis and eczema

320

1983

1.06

0.44

1.0

286.94

337.65

ng/l

1.49

230

1410

Benign neoplasm: Adrenal gland

202

1.24

0.43

1.0

309.59

346.11

ng/l

0.33

132

Thyroiditis, ILD-related definition

202

1.24

0.43

1.0

330.47

339.34

ng/l

0.05

145

Superficial injury of forearm

157

1.28

0.43

1.0

279.46

299.58

ng/l

0.21

103

Ankylosing spondylitis, ICD10

184

1.25

0.43

1.0

282.20

290.72

ng/l

0.08

125

Benign neoplasm: Stomach

266

1.20

0.43

1.1

1.0

380.86

351.81

ng/l

0.19

175

Injury of eye and orbit

266

1.20

0.43

1.0

288.38

321.23

ng/l

0.44

185

Diseases of external ear

820

1.11

0.43

1.0

282.00

323.66

ng/l

0.90

574

Diabetic retinopathy

504

1.12

0.43

1.0

266.13

295.02

ng/l

0.60

353

Malignant neoplasm of bladder

162

0.74

0.42

1.0

372.71

298.49

ng/l

—

100

Other sexually transmitted chlamydial diseases

1.56

0.42

1.0

188.40

213.54

ng/l

—

Other systemic involvement of connective tissue

638

0.88

0.42

1.0

356.09

347.23

ng/l

0.09

438

Injuries to the ankle and foot

149

1467

0.92

0.41

1.0

292.26

328.39

ng/l

0.58

113

1054

LSIL lesion of the cervix uteri, vagina or vulva

176

1.25

0.41

1.0

264.57

338.08

ng/l

1.16

132

Atopic dermatitis, strict definition with reimbursement

430

1.15

0.41

1.0

259.07

312.64

ng/l

1.41

318

Toxoplasmosis

0.00

0.41

0.0

1.0

—

273.25

—

Osteopathy in diseases classified elsewhere

0.00

0.41

0.0

1.0

—

271.70

—

Anuria and oliguria

0.00

0.41

0.0

1.0

—

273.00

—

Carcinoma in situ of breast, lobular

0.00

0.41

0.0

1.0

—

279.90

—

Disorders of plasma-protein metabolism, not elsewhere classified

0.00

0.41

0.0

1.0

—

258.44

—

Increased muscle tone

0.00

0.41

0.0

1.0

—

234.67

—

Other specified/unspecified nutritional deficiencies

0.00

0.41

0.0

1.0

—

261.90

—

Other injuries of spine and trunk, level unspecified

0.00

0.41

0.0

1.0

—

247.71

—

Melanocytic naevi of lip

0.00

0.41

0.0

1.0

—

260.33

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

0.00

0.41

0.0

1.0

—

255.00

—

Cholecystectomy

188

1780

0.93

0.41

1.0

326.75

344.05

ng/l

0.25

122

1264

Striae atrophicae

0.00

0.41

0.0

1.0

—

296.11

—

Infarction of spleen

0.00

0.41

0.0

1.0

—

252.67

—

ILD medications: nintedanib

0.00

0.41

0.0

1.0

—

286.00

—

Rheumatoid arthritis

838

0.90

0.41

1.0

335.25

326.25

ng/l

0.14

586

Bus occupant injured in other and unspecified transport accidents

0.00

0.41

0.0

1.0

—

258.60

—

Complications peculiar to reattachment and amputation

0.00

0.41

0.0

1.0

—

268.25

—

Lung transplant status

0.00

0.41

0.0

1.0

—

242.00

—

Lung transplantation

0.00

0.41

0.0

1.0

—

242.00

—

Other and unspecified disorders of pigmentation

0.00

0.41

0.0

1.0

—

258.44

—

Other injuries of lower limb, level unspecified

0.00

0.41

0.0

1.0

—

273.25

—

Myelodysplastic syndrome

0.00

0.41

0.0

1.0

—

282.50

—

Presence of other devices

566

1.13

0.41

1.1

1.0

412.06

331.33

ng/l

0.83

359

Unspecified human immunodeficiency virus [HIV] disease

0.00

0.41

0.0

1.0

—

213.40

—

Arthropathy in Crohn disease

0.00

0.41

0.0

1.0

—

277.44

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

351

1.17

0.41

1.0

345.42

314.32

ng/l

0.25

258

Pregnancy, childbirth and the puerperium

275

1.14

0.41

1.0

361.42

308.76

ng/l

0.60

176

Paget disease

0.00

0.41

0.0

1.0

—

278.00

—

Osteitis due to dental implant

0.00

0.41

0.0

1.0

—

274.64

—

Fibrosis of liver

0.00

0.41

0.0

1.0

—

273.00

—

Leiomyosarcoma

0.00

0.41

0.0

1.0

—

270.44

—

Aspergillosis

0.00

0.41

0.0

1.0

—

251.18

—

Complications following myocardial infarction

0.00

0.41

0.0

1.0

—

296.33

—

Blindness, monocular

0.00

0.41

0.0

1.0

—

271.78

—

Other and unspecified acquired haemolytic anaemias

0.00

0.41

0.0

1.0

—

238.33

—

Other and unspecified acne

0.00

0.40

0.0

1.0

—

260.80

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

0.00

0.40

0.0

1.0

—

248.92

—

Use of glatiramer acetate

0.00

0.40

0.0

1.0

—

220.67

—

Polycystic ovarian syndrome

0.00

0.40

0.0

1.0

—

271.45

—

Gonarthrosis,primary

316

1884

1.05

0.40

1.0

321.27

335.90

ng/l

0.25

216

1354

Diseases of arteries, arterioles and capillaries (FINNGEN)

541

0.89

0.40

1.0

330.08

346.85

ng/l

0.20

409

Demyelinating diseases of the central nervous system

132

1.29

0.40

1.2

1.0

204.73

289.92

ng/l

1.67

Delivery

454

1.11

0.40

1.0

329.05

338.71

ng/l

0.11

311

Atlantoaxial subluxation

0.00

0.40

0.0

1.0

—

305.83

—

Polyarteritis nodosa

0.00

0.40

0.0

1.0

—

288.10

—

Cervical root disorders

0.00

0.40

0.0

1.0

—

254.50

—

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

0.00

0.40

0.0

1.0

—

258.83

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.40

0.0

1.0

—

240.60

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.40

0.0

1.0

—

277.92

—

Malignant neoplasm of parotid gland

0.00

0.40

0.0

1.0

—

265.00

—

Malignant neoplasm of eye and adnexa

0.00

0.40

0.0

1.0

—

287.44

—

Use of entacapone

0.00

0.40

0.0

1.0

—

270.20

—

Acute mastoiditis

0.00

0.40

0.0

1.0

—

277.38

—

Other systemic involvement of connective tissue (FG)

631

0.88

0.40

1.0

356.09

332.78

ng/l

0.28

422

Benign neoplasm: Short bones of lower limb

0.00

0.40

0.0

1.0

—

296.45

—

Migraine without aura, drug-induced

0.00

0.40

0.0

1.0

—

228.67

—

Nail disorders

150

1.27

0.40

1.1

1.0

239.21

288.34

ng/l

0.56

101

Use of cabergoline

0.00

0.40

0.0

1.0

—

269.44

—

Assault by sharp object

0.00

0.40

0.0

1.0

—

221.83

—

Wet age-related macular degeneration

351

0.84

0.40

1.1

1.0

293.06

338.40

ng/l

0.49

213

Congenital malformations of great arteries

0.00

0.40

0.0

1.0

—

268.11

—

Ectopic pregnancy

368

0.84

0.39

1.0

276.60

432.67

ng/l

0.91

274

Sequelae of other external causes

104

0.67

0.39

1.1

1.0

264.71

330.49

ng/l

—

Acute drug-induced interstitial lung disorder

0.00

0.39

0.0

1.0

—

283.70

—

Glaucoma secondary to eye inflammation

0.00

0.39

0.0

1.0

—

262.50

—

Intracranial and intraspinal abscess and granuloma

0.00

0.39

0.0

1.0

—

260.36

—

Traumatic amputation of wrist and hand

106

1.32

0.39

1.0

356.25

297.54

ng/l

—

Certolizumab pegol

0.00

0.39

0.0

1.0

—

286.67

—

Benign neoplasm of eye and adnexa

237

0.80

0.39

1.0

312.36

324.06

ng/l

0.08

151

Complications of labour and delivery

137

827

0.92

0.38

1.0

387.25

359.25

ng/l

0.17

101

606

Non-allergic asthma

187

1.23

0.38

1.0

363.25

341.08

ng/l

0.12

119

Other necrotizing vasculopathies (FG)

142

1.27

0.38

1.0

331.83

325.76

ng/l

0.03

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.39

0.38

1.0

244.00

444.84

ng/l

—

Anomalies of dental arch relationship, including avohilmo

271

0.83

0.38

1.0

287.78

315.59

ng/l

0.30

193

Single spontaneous delivery

454

1.10

0.37

1.0

328.77

338.71

ng/l

0.11

311

Other/unspecified rheumatoid arthritis

301

0.83

0.37

1.0

299.71

340.11

ng/l

0.54

197

Other symptoms and signs involving the urinary system

243

1.19

0.37

1.0

249.12

306.80

ng/l

1.30

161

Biomechanical lesions, not elsewhere classified

1.33

0.37

1.0

238.86

319.40

ng/l

—

Bacterial pneumonia (organism specified)

102

1014

0.92

0.37

1.0

234.59

334.93

ng/l

8.75

690

AV-block

458

0.87

0.37

1.0

263.66

363.18

ng/l

2.49

285

Complications of medical and surgical care

213

1904

1.06

0.37

1.0

467.04

320.41

ng/l

0.43

158

1336

Superficial injury of wrist and hand

336

1.16

0.37

1.0

283.47

325.16

ng/l

0.48

237

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

673

0.89

0.37

1.1

1.0

244.90

332.76

ng/l

1.65

492

Other disorders of white blood cells

116

0.69

0.37

1.0

282.13

298.51

ng/l

—

Obesity, other/unspecified

725

0.90

0.36

1.0

232.06

369.93

ng/l

1.86

526

Other heart diseases, wide

286

1684

1.05

0.36

1.0

302.31

338.55

ng/l

0.74

206

1221

Acute bronchitis

905

0.91

0.36

1.0

239.73

331.45

ng/l

3.66

609

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

658

1.11

0.36

1.0

778.28

319.45

ng/l

0.47

469

Other inflammation of eyelid

281

1.18

0.36

1.0

288.23

338.72

ng/l

1.04

189

Other disorders of prostate

1.36

0.36

1.0

216.17

298.98

ng/l

—

Chalazion

244

1.19

0.36

1.1

1.0

334.57

334.51

ng/l

0.00

167

Other noninflammatory disorders of uterus, except cervix

409

0.88

0.36

1.0

367.52

339.08

ng/l

0.37

286

Coeliac disease

244

1.19

0.36

1.0

332.04

328.25

ng/l

0.02

166

Endometriosis ASRM stages 3,4

412

1.14

0.36

1.0

354.45

351.31

ng/l

0.02

291

Complications predominantly related to the puerperium

431

1.14

0.36

1.0

302.88

419.52

ng/l

0.72

315

Urticaria and erythema

754

1.10

0.36

1.0

284.69

325.05

ng/l

0.97

539

Separation of retinal layers (serosa)

1.34

0.35

1.1

1.0

194.00

253.89

ng/l

—

Heartburn

226

1.20

0.35

1.1

1.0

271.29

325.15

ng/l

1.17

158

Chronic periapical parodontitis

523

0.88

0.35

1.0

992.00

334.63

ng/l

0.45

367

Hypertrophy of breast in women and men

394

1.14

0.35

1.0

308.94

333.19

ng/l

0.23

276

Glucosamine medication

168

1255

1.07

0.35

1.0

320.68

335.52

ng/l

0.25

112

869

Other female pelvic inflammatory diseases

338

1.15

0.35

1.0

304.62

371.42

ng/l

0.77

235

Congenital malformations, deformations and chromosomal abnormalities

131

1165

1.08

0.35

1.0

291.59

335.16

ng/l

0.60

843

Undetermined asthma

309

0.84

0.35

1.0

392.80

344.14

ng/l

0.26

209

Arthropod-borne viral fevers and viral haemorrhagic fevers

233

0.81

0.34

1.1

1.0

208.07

307.68

ng/l

2.20

161

Benign neoplasm: Colon

179

1288

1.07

0.34

1.0

286.17

329.92

ng/l

1.56

125

896

Direct fill therapy

287

0.84

0.34

1.0

312.00

332.99

ng/l

0.23

197

Paralytic ileus and intestinal obstruction

651

1.11

0.34

1.0

291.04

337.27

ng/l

1.09

449

Injuries to unspecified part of trunk, limb or body region

189

0.79

0.34

1.0

329.50

302.67

ng/l

—

121

Diseases of the digestive system

121

1119

1.08

0.34

1.0

308.10

332.44

ng/l

0.37

765

Excessive attrition of teeth

487

1.09

0.34

1.0

273.92

341.28

ng/l

2.06

348

Coxarthrosis

177

1127

1.07

0.34

1.0

338.33

313.70

ng/l

0.22

117

805

Azathioprine

311

1.16

0.34

1.0

341.86

326.29

ng/l

0.10

221

Plantar fascial fibromatosis

209

1.20

0.34

1.0

281.56

348.86

ng/l

1.18

142

Other bacterial intestinal infections

396

1.14

0.33

1.0

284.45

333.80

ng/l

1.13

266

Superficial injury of hip and thigh

302

1.16

0.33

1.0

305.96

308.87

ng/l

0.02

199

Other septicaemia

894

1.09

0.33

1.0

307.11

350.15

ng/l

0.77

609

Ill-defined and unknown causes of mortality

136

1.25

0.33

1.0

330.44

298.55

ng/l

—

Infections with a predominantly sexual mode of transmission

462

1.12

0.33

1.0

276.05

327.51

ng/l

1.17

333

Asthma, including avohilmo

347

1929

1.05

0.33

1.0

289.51

336.74

ng/l

1.33

239

1381

Otitis externa

472

1.12

0.33

1.0

303.34

321.53

ng/l

0.20

336

Abrasion of teeth

479

1.11

0.33

1.0

260.19

342.07

ng/l

2.26

346

Problems related to lifestyle

191

1.21

0.33

1.0

271.53

325.88

ng/l

0.77

128

ILD medications: azathioprine

312

1.15

0.33

1.0

341.86

322.25

ng/l

0.13

217

Codeine or tramadol medication

349

1850

1.04

0.33

1.0

379.49

325.15

ng/l

0.22

248

1311

Other benign neoplasms of skin

100

1063

0.92

0.33

1.0

344.77

339.11

ng/l

0.06

729

Benign neoplasm of ovary

397

1.13

0.32

1.0

280.91

364.92

ng/l

1.64

279

Other arrhythmias

189

1533

0.94

0.32

1.0

315.70

348.32

ng/l

0.53

129

1100

Asthma-related pneumonia

825

1.09

0.32

1.0

293.45

333.63

ng/l

0.87

560

Delivery, wide proxy

336

1.11

0.32

1.0

351.78

321.89

ng/l

0.34

215

Other condition

275

1.16

0.32

1.0

361.05

321.69

ng/l

0.38

191

Obstructed labour due to maternal pelvic abnormality

350

1.14

0.32

1.0

512.97

419.55

ng/l

0.20

257

Seronegative rheumatoid arthritis

285

0.84

0.32

1.0

362.94

340.10

ng/l

0.16

200

Other congenital malformations of circulatory system

1.28

0.32

1.0

189.83

266.60

ng/l

—

Other metabolic disorders

238

1.18

0.32

1.0

288.71

353.34

ng/l

0.46

159

Other and unspecified dermatitis

141

1319

1.07

0.32

1.0

271.08

342.95

ng/l

1.48

931

Other contact dermatitis

155

1.23

0.32

1.1

1.0

312.92

318.56

ng/l

0.03

102

Chronic laryngitis and laryngotracheitis

360

1.14

0.32

1.0

348.41

321.79

ng/l

0.23

253

Asthma-related pneumonia or sepsis

826

1.09

0.32

1.0

293.45

333.22

ng/l

0.86

561

Asthma, hospital admissions 3, pneumonia

826

1.09

0.32

1.0

293.45

333.22

ng/l

0.86

561

Opioids

304

1524

1.05

0.32

1.0

261.50

331.65

ng/l

5.72

228

1077

Secondary hypertension

172

1.21

0.32

1.1

1.0

316.73

341.25

ng/l

0.17

122

Ulcerative colitis

531

1.11

0.31

1.0

270.44

322.46

ng/l

1.59

375

Dermatitis

172

1621

1.06

0.31

1.0

269.39

346.20

ng/l

2.20

119

1148

Excessive, frequent and irregular menstruation

443

1.09

0.31

1.0

377.41

335.05

ng/l

0.21

313

Vitamin B12 deficiency anaemia

248

1.17

0.31

1.1

1.0

246.56

314.94

ng/l

0.85

158

Benign neoplasm: Tongue

1.35

0.31

1.1

1.0

169.00

332.70

ng/l

—

Inguinal hernia, bilateral

267

1.16

0.31

1.0

267.35

304.59

ng/l

0.43

181

Other necrotizing vasculopathies

156

1.22

0.31

1.0

326.08

318.30

ng/l

0.05

Erysipelas

166

1427

1.06

0.31

1.0

269.26

323.84

ng/l

2.64

106

997

Preparatory care for dialysis

0.73

0.31

1.0

435.29

281.29

ng/l

—

Short Achilles tendon (acquired)

1.32

0.31

1.3

1.0

278.29

335.56

ng/l

—

Endometriosis of pelvic peritoneum

273

1.16

0.30

1.0

352.24

335.47

ng/l

0.12

200

Other symptoms and signs involving the digestive system and abdomen

352

1.14

0.30

1.0

299.97

351.34

ng/l

0.86

239

Other anaemias

1031

0.93

0.30

1.0

340.71

346.39

ng/l

0.06

690

Undetermined asthma, excluding more controls

304

0.85

0.30

1.0

392.80

346.64

ng/l

0.25

205

Benign neoplasm of other and ill-defined parts of digestive system

447

1.12

0.30

1.0

342.66

336.76

ng/l

0.05

309

Phlebitis and thrombophlebitis (not including DVT)

558

0.90

0.30

1.0

277.91

322.11

ng/l

0.82

399

Other acute lower respiratory infections

110

1128

0.93

0.30

1.0

230.84

321.74

ng/l

5.04

781

Codeine

290

1523

1.05

0.30

1.0

390.44

331.82

ng/l

0.19

206

1076

Disorders of calcium metabolism

129

1.24

0.30

1.0

386.80

336.29

ng/l

—

Disorders of vitreous body and globe

163

1499

1.06

0.30

1.0

329.57

354.90

ng/l

0.36

114

1061

Peritonsillar abscess

410

0.88

0.30

1.0

254.70

303.23

ng/l

0.87

297

Hallux valgus (acquired)

109

733

1.08

0.29

1.0

359.52

330.09

ng/l

0.48

514

Chronic sinusitis

118

1101

1.07

0.29

1.0

303.69

315.21

ng/l

0.20

782

Benign lipomatous neoplasm

774

1.09

0.29

1.0

332.67

329.37

ng/l

0.04

543

Disorders of mineral metabolism

185

1.19

0.29

1.0

318.14

343.14

ng/l

0.10

120

Recurring oral aphthae, including avohilmo

281

0.85

0.28

1.0

324.13

323.25

ng/l

0.01

182

Congenital malformations of heart and great arteries

220

0.84

0.28

1.0

261.64

311.05

ng/l

0.63

150

Other ill-defined and unspecified causes of mortality

121

1.24

0.28

1.0

363.57

307.76

ng/l

—

Combinations of oral blood glucose lowering drugs

853

1.08

0.28

1.1

1.0

287.66

336.08

ng/l

0.62

607

Noninflammatory disorders of female genital tract

443

0.92

0.28

1.0

316.12

335.05

ng/l

0.35

313

Lichen planus, including avohilmo

450

1.11

0.28

1.0

292.19

335.87

ng/l

0.64

317

Retinal vascular occlusion

270

1.15

0.28

1.0

288.24

307.58

ng/l

0.20

166

Other specified/unspecified hearing loss

186

1.18

0.28

1.1

1.0

274.41

310.92

ng/l

0.48

120

Dipeptidyl peptidase 4 (DPP-4) inhibitors

327

1.13

0.27

1.1

1.0

230.10

337.01

ng/l

3.65

219

Rosacea

233

1.16

0.27

1.0

333.42

334.96

ng/l

0.01

160

Disturbances of skin sensation

556

1.10

0.27

1.0

273.17

322.46

ng/l

1.09

402

Other and unspecified anaemias

1027

0.93

0.27

1.0

340.71

346.71

ng/l

0.07

689

Sarcoidosis

318

1.13

0.27

1.0

311.03

329.43

ng/l

0.23

221

Other otitis externa (chronic)

131

1.22

0.27

1.0

202.44

291.42

ng/l

—

Benign neoplasm: Rectum, anus and anal canal

547

1.10

0.27

1.0

314.76

333.41

ng/l

0.30

364

Other and unspecified iron deficiency

740

0.92

0.27

1.0

314.84

340.75

ng/l

0.32

499

Calculus of kidney and ureter

792

0.92

0.27

1.0

292.27

314.16

ng/l

0.28

554

Other shoulder lesions

187

1.18

0.26

1.0

253.06

350.42

ng/l

1.91

129

Internal derangement of knee

109

1018

1.07

0.26

1.0

261.01

305.29

ng/l

1.37

730

Endometriosis ASRM stages 1,2

281

1.14

0.26

1.0

352.24

360.03

ng/l

0.05

203

Visual field defects

182

0.82

0.26

1.1

1.0

801.60

308.60

ng/l

—

117

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

0.68

0.26

1.0

471.60

373.10

ng/l

—

Inguinal or femoral hernia, bilateral

272

1.14

0.26

1.0

267.35

306.07

ng/l

0.45

182

Hernia of abdominal wall

116

1234

0.94

0.26

1.0

277.82

322.74

ng/l

1.25

862

ILD medications: prednisolone, methylprednisolone, prednisone

311

1825

0.96

0.26

1.0

295.95

329.41

ng/l

0.77

221

1304

Spondyloarthritis

367

1.12

0.25

1.0

259.85

317.38

ng/l

1.51

263

Asthma, unspecified (mode), excluding more controls

155

1153

1.06

0.25

1.0

274.25

336.99

ng/l

2.76

111

811

Glomerular disorders in diseases classified elsewhere

267

0.86

0.25

1.0

363.33

304.77

ng/l

0.57

185

Persons encountering health services in circumstances related to reproduction

137

983

0.94

0.25

1.0

301.57

346.34

ng/l

0.52

102

746

Major coronary heart disease event

230

1602

0.96

0.25

1.0

288.59

324.71

ng/l

1.33

150

1128

Trigger finger

339

1.12

0.25

1.0

273.03

359.02

ng/l

1.48

243

Other disorders of optic [2nd] nerve and visual pathways

114

1.23

0.25

1.0

334.11

302.07

ng/l

—

Uterine polyps

213

0.84

0.25

1.0

270.08

345.82

ng/l

1.12

154

Pregnancy hypertension

711

0.93

0.25

1.1

1.0

844.40

321.34

ng/l

0.54

531

Other diseases of anus and rectum

742

1.08

0.25

1.0

293.61

337.15

ng/l

0.83

510

Other arthritis (FG)

809

0.93

0.25

1.0

365.04

364.16

ng/l

0.00

561

Benign neoplasm: Rectum

531

1.09

0.24

1.0

317.79

342.81

ng/l

0.43

351

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

198

1.16

0.24

1.0

405.00

328.08

ng/l

0.36

126

Obesity due to excess calories

115

1083

1.06

0.24

1.0

230.49

346.22

ng/l

2.75

783

Superficial injury of ankle and foot

191

0.84

0.24

1.1

1.0

298.90

304.83

ng/l

—

126

Coxarthrosis [arthrosis of hip](FG)

194

1340

1.05

0.24

1.0

335.95

345.65

ng/l

0.07

128

947

Other and unspecified disorders of white blood cells

0.73

0.24

1.0

240.50

273.21

ng/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

161

1.18

0.24

1.1

1.0

295.54

312.80

ng/l

0.15

105

Atopic dermatitis

118

949

1.06

0.24

1.0

292.85

345.34

ng/l

0.62

691

Contact with machinery

286

0.87

0.23

1.0

304.28

291.02

ng/l

0.11

206

Dental caries

585

1.08

0.23

1.0

800.48

329.43

ng/l

0.48

407

HSIL lesion of the cervix uteri, vagina or vulva

222

0.86

0.23

1.0

262.08

331.87

ng/l

1.13

164

Granulomatous disorders of skin and subcutaneous tissue

1.32

0.23

1.0

260.80

323.87

ng/l

—

Impacted cerumen

218

1.15

0.23

1.0

213.00

309.16

ng/l

2.08

142

Asthma/COPD (KELA code 203)

275

1868

1.04

0.23

1.0

301.57

338.77

ng/l

0.81

191

1332

Diseases of the respiratory system

214

1027

1.04

0.23

1.0

316.11

339.35

ng/l

0.50

149

729

Ulcerative colitis, NAS

285

0.88

0.23

1.0

304.47

330.95

ng/l

0.28

204

Disorders of vitreous body

158

1474

1.05

0.22

1.0

330.03

356.38

ng/l

0.37

113

1042

5-aminosalicylic acid

457

1.09

0.22

1.0

317.15

320.63

ng/l

0.03

328

Hypertrophy of breast

323

1.12

0.22

1.0

319.43

346.38

ng/l

0.22

235

Benign neoplasm: Vulva

1.25

0.22

1.0

526.20

362.58

ng/l

—

Other skin changes

400

0.90

0.22

1.1

1.0

292.59

335.03

ng/l

0.65

269

Triptan medication for migraine, min. 3 purchases

106

887

0.94

0.22

1.0

271.72

355.37

ng/l

1.22

666

Effects of foreign body entering through natural orifice

544

1.08

0.22

1.0

321.64

301.11

ng/l

0.16

389

Postmenopausal atrophic vaginitis

429

0.93

0.22

1.0

332.39

339.08

ng/l

0.09

306

All dysplastic lesions of the cervix uteri

294

0.88

0.22

1.0

267.61

336.92

ng/l

1.21

223

Allergic purpura

1.22

0.22

1.0

259.20

251.33

ng/l

—

Macular hole

144

1.18

0.22

1.0

345.36

316.07

ng/l

0.20

Septicaemia

109

990

1.06

0.22

1.0

300.26

347.01

ng/l

0.95

675

Zoster [herpes zoster]

410

1.10

0.22

1.1

1.0

237.75

336.82

ng/l

3.23

276

Benign neoplasm: Ascending colon

343

1.11

0.22

1.0

261.40

324.44

ng/l

1.18

230

Other disorders of the genitourinary system

305

1.12

0.21

1.0

451.65

358.78

ng/l

0.67

206

Benign neoplasm: Ciliary body

0.00

0.21

0.0

1.0

—

271.50

—

Benign neoplasm: Ciliary body

0.00

0.21

0.0

1.0

—

271.50

—

Cytomegaloviral hepatitis

0.00

0.21

0.0

1.0

—

262.80

—

Biliary cirrhosis, NAS

0.00

0.21

0.0

1.0

—

273.00

—

Other degenerative disorders of eyelid and periocular area

0.00

0.21

0.0

1.0

—

286.80

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.21

0.0

1.0

—

321.00

—

Toxic colitis

0.00

0.21

0.0

1.0

—

293.00

—

Malignant neoplasm of thymus

0.00

0.21

0.0

1.0

—

262.80

—

Crushing injury of ankle and foot

0.00

0.21

0.0

1.0

—

267.60

—

Abnormal findings in peritoneal fluid saliva

0.00

0.21

0.0

1.0

—

256.50

—

Malignant neoplasm of hypopharynx

0.00

0.21

0.0

1.0

—

249.40

—

Malignant neoplasm of gum

0.00

0.21

0.0

1.0

—

297.00

—

Systemic disorders of connective tissue in diseases classified elsewhere

0.00

0.21

0.0

1.0

—

301.00

—

Drowning and submersion while in natural water

0.00

0.21

0.0

1.0

—

245.60

—

Neuroendocrine tumor and carcinoma of stomach

0.00

0.21

0.0

1.0

—

290.83

—

Congenital malformations of oesophagus

0.00

0.21

0.0

1.0

—

228.17

—

Iron deficiency anaemia

968

0.94

0.21

1.0

330.73

333.38

ng/l

0.03

655

Systemic sclerosis, icd10

1.19

0.21

1.0

422.20

352.69

ng/l

—

Severe visual impairment, binocular

0.00

0.21

0.0

1.0

—

305.80

—

Perforation of oesophagus

0.00

0.21

0.0

1.0

—

250.20

—

Acquired clawhand, clubhand, clawfoot and clubfoot

0.00

0.21

0.0

1.0

—

247.80

—

Deaf mutism, not elsewhere classified

0.00

0.21

0.0

1.0

—

288.80

—

Juvenile Open Angle Glaucoma

0.00

0.21

0.0

1.0

—

262.80

—

Acute myringitis

0.00

0.21

0.0

1.0

—

272.67

—

Other specified congenital malformation syndromes affecting multiple systems

0.00

0.21

0.0

1.0

—

212.17

—

Bacterial intestinal infections, IBD co-morbidities

401

1.10

0.21

1.0

294.77

326.82

ng/l

0.58

266

Other peripheral vertigo

220

0.86

0.21

1.1

1.0

262.71

316.11

ng/l

0.78

140

Nezelof syndrome

0.00

0.21

0.0

1.0

—

245.29

—

Other/unspecified mastoiditis and related conditions

0.00

0.21

0.0

1.0

—

275.00

—

Renal agenesis and other reduction defects of kidney

0.00

0.21

0.0

1.0

—

250.83

—

Other dermatomyositis

0.00

0.21

0.0

1.0

—

293.71

—

Benign neoplasm: Retina

0.00

0.21

0.0

1.0

—

302.43

—

Lower leg

0.00

0.21

0.0

1.0

—

302.83

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

0.21

0.0

1.0

—

290.71

—

0.00

0.21

0.0

1.0

—

278.80

—

Mesial bite

0.00

0.21

0.0

1.0

—

269.71

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.00

0.21

0.0

1.0

—

236.86

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

315

1.11

0.21

1.0

304.37

315.97

ng/l

0.14

226

Rheumatoid lung disease

0.00

0.21

0.0

1.0

—

271.38

—

Left side

0.00

0.21

0.0

1.0

—

244.37

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.21

0.0

1.0

—

301.00

—

0.00

0.21

0.0

1.0

—

289.88

—

Carcinoma in situ of endometrium

0.00

0.21

0.0

1.0

—

222.00

—

Asthma, unspecified (mode)

157

1189

1.05

0.21

1.0

278.90

334.71

ng/l

2.23

112

835

ILD and respiratory illness in diseases classified elsewhere

0.00

0.21

0.0

1.0

—

289.88

—

Blindness or visual impairment, binocular

0.00

0.21

0.0

1.0

—

293.71

—

Hydrocephalus in other diseases

0.00

0.21

0.0

1.0

—

295.88

—

Benign neoplasm: Retina

0.00

0.21

0.0

1.0

—

302.43

—

Burn and corrosion, body region unspecified

0.00

0.21

0.0

1.0

—

247.71

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.21

0.0

1.0

—

273.00

—

Drug-induced systemic lupus erythematosus

0.00

0.21

0.0

1.0

—

276.57

—

Acute inflammation of orbit

0.00

0.21

0.0

1.0

—

236.40

—

Dacryoadenitis

0.00

0.21

0.0

1.0

—

318.29

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.21

0.0

1.0

—

280.88

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

0.00

0.21

0.0

1.0

—

238.63

—

Chronic pancreatitis

335

0.89

0.20

1.0

195.43

317.33

ng/l

5.08

243

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

198

0.86

0.20

1.0

277.33

361.64

ng/l

0.70

132

Carcinoma in situ of endometrium

0.00

0.20

0.0

1.0

—

231.63

—

Typhoid and paratyphoid fevers

0.00

0.20

0.0

1.0

—

279.29

—

Benign leiomyoma with endometriosis

364

1.10

0.20

1.0

370.32

352.94

ng/l

0.12

251

Dermatopolymyositis, unspecified

0.00

0.20

0.0

1.0

—

295.88

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

0.00

0.20

0.0

1.0

—

228.33

—

Reiter disease

0.00

0.20

0.0

1.0

—

274.14

—

Deformity of finger(s)

0.00

0.20

0.0

1.0

—

238.11

—

Valgus deformity, not elsewhere classified

0.00

0.20

0.0

1.0

—

259.63

—

Recurrent and persistent haematuria

0.00

0.20

0.0

1.0

—

264.63

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.20

0.0

1.0

—

274.89

—

Ventral hernia

594

0.93

0.20

1.1

1.0

287.02

335.56

ng/l

0.78

418

Retinal vascular disorders

278

1.12

0.20

1.0

288.24

305.34

ng/l

0.17

170

Open wound of forearm

155

0.84

0.20

1.0

293.86

290.42

ng/l

—

102

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

202

1.14

0.20

1.0

405.00

363.76

ng/l

0.17

134

Other disorders of iris and ciliary body

1.23

0.20

1.0

291.50

289.07

ng/l

—

Carcinoma in situ of breast, intraductal

208

0.86

0.20

1.0

352.54

379.37

ng/l

0.19

146

Missing teeth due to accident, extraction or parodontitis

292

0.89

0.20

1.0

360.68

336.73

ng/l

0.23

204

Asthma-related infections

144

1354

1.05

0.19

1.0

283.76

345.04

ng/l

0.97

940

Asthma, hospital admission 2, infections

144

1354

1.05

0.19

1.0

283.76

345.04

ng/l

0.97

940

Pathological resorption of teeth

1.20

0.19

1.2

1.0

383.83

281.50

ng/l

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1.20

0.19

1.0

324.83

250.05

ng/l

—

Benign neoplasm: Transverse colon

269

1.12

0.19

1.0

301.14

320.13

ng/l

0.21

181

Urolithiasis

871

0.94

0.19

1.0

299.57

317.84

ng/l

0.22

606

Benign neoplasm: Parotid gland

197

0.86

0.19

1.1

1.0

371.00

338.11

ng/l

0.17

130

Oral lichen ruber planus wide, hypothyreosis or thyroxin

127

1.18

0.19

1.1

1.0

283.56

336.73

ng/l

—

Calcific tendinitis of shoulder

127

1.18

0.19

1.0

294.70

349.73

ng/l

—

Acne

1.18

0.19

1.2

1.0

201.67

206.74

ng/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

539

1.08

0.19

1.0

332.27

341.38

ng/l

0.08

383

Lichen planus

327

1.10

0.19

1.1

1.0

324.17

335.88

ng/l

0.09

222

Carcinoma in situ of breast, intraductal

207

0.87

0.19

1.0

352.54

368.77

ng/l

0.11

144

Thyrotoxicosis

561

0.93

0.19

1.0

267.05

345.28

ng/l

1.23

390

Polyp of the female genital tract

441

0.94

0.19

1.0

282.15

335.59

ng/l

1.23

312

Macular pucker

426

0.91

0.18

1.0

326.82

332.13

ng/l

0.05

275

Other disorders of skin and subcutaneous tissue, not elsewhere classified

322

0.90

0.18

1.1

1.0

264.90

328.12

ng/l

0.99

217

Open wound of wrist and hand

104

978

1.05

0.18

1.0

253.49

302.84

ng/l

2.46

698

Certain disorders involving the immune mechanism

453

1.08

0.18

1.0

281.98

323.28

ng/l

0.86

320

Other diseases of the digestive system

793

1.06

0.18

1.0

279.37

326.77

ng/l

1.14

538

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

287

1996

1.03

0.18

1.0

317.09

333.94

ng/l

0.30

221

1405

Other embolism and thrombosis

309

1.10

0.18

1.1

1.0

345.36

316.33

ng/l

0.27

213

Haemorrhoids and perianal venous thrombosis

764

1.06

0.18

1.0

305.91

338.78

ng/l

0.43

518

Other viral diseases, not elsewhere classified

318

1.10

0.18

1.0

302.16

315.03

ng/l

0.09

221

Other disorders of skin and subcutaneous tissue

198

1751

1.04

0.18

1.0

305.74

347.02

ng/l

0.81

131

1231

Striking against or struck by other objects

648

1.06

0.17

1.0

300.23

300.37

ng/l

0.00

461

Benign neoplasm: Skin of eyelid, including canthus

377

1.09

0.17

1.1

1.0

324.18

327.86

ng/l

0.03

256

Reactive arthropathies

195

0.87

0.17

1.0

314.50

338.23

ng/l

0.12

139

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

123

745

1.05

0.17

1.0

296.00

330.80

ng/l

0.93

574

Benign neoplasm: Tongue

1.13

0.17

1.1

1.0

169.00

342.55

ng/l

—

GI-bleeding

786

1.06

0.17

1.0

251.96

329.21

ng/l

3.99

529

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

330

0.91

0.17

1.0

331.35

327.25

ng/l

0.03

228

Perforation of tympanic membrane

205

1.12

0.17

1.0

290.62

317.72

ng/l

0.26

132

Benign neoplasm of mouth and pharynx

253

1.11

0.16

1.1

1.0

205.50

322.58

ng/l

5.36

166

Conductive hearing loss, unspecified

177

1.13

0.16

1.0

221.36

298.94

ng/l

1.52

120

Procreative management

483

1.07

0.16

1.0

295.83

326.58

ng/l

0.36

355

Vasomotor rhinitis (mode)

158

1.14

0.16

1.0

255.08

315.27

ng/l

0.78

104

Nonalcoholic fatty liver disease

204

0.88

0.16

1.0

227.92

316.07

ng/l

0.83

137

Squamous cell neoplasms and carcinomas of the skin

256

0.90

0.16

1.0

287.31

333.95

ng/l

0.64

155

Unspecified acute lower respiratory infection

302

1.09

0.16

1.0

203.00

314.95

ng/l

3.83

211

Ulcerative colitis (strict definition, all Crohn cases excluded)

283

1.10

0.15

1.0

294.35

322.41

ng/l

0.40

197

Obesity and other hyperalimentation

148

1519

0.96

0.15

1.0

237.81

335.32

ng/l

3.26

109

1097

Other disorders of adrenal gland

0.79

0.15

1.0

295.83

292.46

ng/l

—

Other hearing loss

636

0.94

0.15

1.0

303.57

338.97

ng/l

0.64

425

Vestibular neuronitis

226

1.11

0.15

1.0

253.33

322.31

ng/l

0.88

148

Otitis media, unspecified

120

1.15

0.15

1.0

340.10

275.36

ng/l

—

LSIL lesion of the cervix uteri

121

1.16

0.15

1.0

287.22

332.16

ng/l

—

Other maternal disorders predominantly related to pregnancy

121

792

0.96

0.15

1.0

307.29

375.37

ng/l

0.77

594

Chronic nephritic syndrome

1.10

0.15

1.2

1.0

409.89

281.16

ng/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

213

0.89

0.15

1.1

1.0

371.00

323.54

ng/l

0.27

139

Bacterial pneumonia, not elsewhere classified

870

0.96

0.14

1.1

1.0

233.74

343.10

ng/l

8.70

604

Diabetic nephropathy, excluding more controls

245

1.09

0.14

1.0

365.17

282.78

ng/l

0.75

172

Ulcerative colitis (strict definition, require KELA)

323

1.08

0.14

1.0

304.37

318.64

ng/l

0.18

232

Hallux rigidus

391

1.07

0.14

1.0

372.00

338.17

ng/l

0.23

271

Other disorders of eyelid

124

1244

0.96

0.14

1.0

289.05

363.55

ng/l

1.30

855

Correction of physiology of bite - demanding therapy visit

112

1.16

0.14

1.1

1.0

310.88

306.22

ng/l

—

Oral corticosteroids

317

1874

1.02

0.14

1.0

334.56

329.10

ng/l

0.06

225

1338

Cholecystitis

326

0.92

0.14

1.0

353.50

331.22

ng/l

0.24

222

Acute pancreatitis (for exclusion)

511

0.94

0.14

1.0

321.28

318.74

ng/l

0.03

354

Acute pancreatitis

511

0.94

0.14

1.0

321.28

325.41

ng/l

0.04

361

Vitreous haemorrhage

243

0.90

0.13

1.0

326.88

311.68

ng/l

0.08

163

Other abnormal uterine and vaginal bleeding

394

0.94

0.13

1.0

284.40

340.24

ng/l

1.43

276

Acute appendicitis, no complications

133

1373

0.97

0.13

1.0

270.21

327.95

ng/l

1.20

104

992

Artificial joint operation, meniscal resection

299

1944

1.02

0.13

1.0

345.25

331.23

ng/l

0.22

208

1391

Lichen sclerosus et atrophicus

218

1.10

0.13

1.0

314.43

340.28

ng/l

0.14

148

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

162

1664

0.97

0.13

1.0

306.51

322.64

ng/l

0.28

119

1152

Disorders of gallbladder, biliary tract and pancreas

295

1944

0.98

0.13

1.0

301.28

335.66

ng/l

0.83

195

1393

Tuberculosis, IBD comorbidity

151

1.13

0.13

1.1

1.0

249.30

306.63

ng/l

—

Contraceptive management

689

0.96

0.13

1.0

312.90

353.30

ng/l

0.31

541

Other obstetric conditions, not elsewhere classified

104

1.12

0.13

1.0

270.85

259.05

ng/l

0.08

Autoimmune diseases related-to ILD

226

2038

0.98

0.13

1.0

297.90

334.53

ng/l

0.79

157

1462

Other disorders of patella

366

0.93

0.13

1.0

333.52

316.19

ng/l

0.15

268

Exposure to other and unspecified inanimate mechanical forces

117

0.85

0.13

1.1

1.0

279.50

270.22

ng/l

—

Pre-eclampsia

335

0.93

0.13

1.1

1.0

1608.57

350.39

ng/l

0.50

249

Pregnancy with abortive outcome

146

789

0.97

0.13

1.0

366.81

376.51

ng/l

0.07

102

568

Obesity related asthma

864

1.04

0.12

1.0

281.34

323.21

ng/l

0.92

604

Obesity

148

1511

0.97

0.12

1.0

237.81

335.76

ng/l

3.26

109

1092

Diabetic retinopathy, strict definition

303

1.07

0.12

1.0

295.93

276.67

ng/l

0.18

216

Radial styloid tenosynovitis [de Quervain]

1.18

0.12

1.0

178.20

337.24

ng/l

—

Disorders of muscles

210

0.90

0.12

1.0

297.09

341.97

ng/l

0.50

147

Foreign body on external eye

344

0.93

0.12

1.0

341.54

291.27

ng/l

0.24

251

Primary coxarthrosis, bilateral

803

0.96

0.11

1.0

255.47

330.70

ng/l

3.46

541

Postmenopausal bleeding

432

1.04

0.11

1.0

317.00

338.42

ng/l

0.29

307

Glomerular diseases

425

0.94

0.11

1.1

1.0

347.34

316.13

ng/l

0.32

295

Benign neoplasm: Skin of other and unspecified parts of face

271

0.92

0.11

1.0

399.39

345.18

ng/l

0.23

175

Lymphoid leukaemia

126

0.87

0.11

1.2

1.0

242.40

347.67

ng/l

—

Bacterial pneumoniae

101

926

0.97

0.11

1.0

234.48

349.67

ng/l

9.09

644

Neoplasms

204

1120

0.98

0.11

1.0

291.77

308.23

ng/l

0.38

146

789

Other/unspecified synovitis and tenosynovitis

260

1.08

0.10

1.0

317.77

352.92

ng/l

0.28

182

Retained placenta and membranes, without haemorrhage

229

0.92

0.10

1.1

1.0

454.53

336.20

ng/l

0.86

166

Orchitis and epididymitis

192

1.09

0.10

1.0

262.13

303.12

ng/l

0.82

124

Acute upper respiratory infections

293

1870

0.98

0.10

1.0

281.29

345.05

ng/l

1.92

214

1320

Fracture of foot, except ankle

485

1.05

0.10

1.1

1.0

307.55

318.73

ng/l

0.11

353

Other disorders of kidney and ureter

309

1.07

0.10

1.0

304.21

310.10

ng/l

0.05

204

Nutritional anaemias

117

1173

0.97

0.10

1.0

317.01

334.55

ng/l

0.26

794

Candidiasis

280

0.93

0.10

1.0

324.86

334.05

ng/l

0.09

184

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

177

0.90

0.10

1.0

283.73

365.44

ng/l

0.60

117

Other and unspecified rosacea

183

1.09

0.10

1.0

379.50

318.56

ng/l

0.34

121

Coronary atherosclerosis

238

1504

1.02

0.10

1.0

299.46

329.40

ng/l

0.93

155

1076

Other diseases of pancreas

193

1.09

0.10

1.0

218.36

321.54

ng/l

1.88

133

Benign neoplasm: Vulva

1.11

0.10

1.0

526.20

382.40

ng/l

—

Systemic sclerosis (FG)

1.11

0.10

1.0

422.20

374.32

ng/l

—

Systemic sclerosis

1.11

0.10

1.0

422.20

351.96

ng/l

—

Symptoms and signs involving the skin and subcutaneous tissue

179

1821

0.98

0.09

1.0

291.92

341.54

ng/l

1.20

132

1283

Other specific arthropathies, wide

1.09

0.09

1.0

255.80

327.62

ng/l

—

Salpingitis and oophoritis

422

0.95

0.09

1.1

1.0

327.28

431.50

ng/l

0.52

303

Leiomyoma of uterus

119

690

0.97

0.09

1.0

658.70

333.04

ng/l

0.57

495

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

174

1.09

0.09

1.1

1.0

295.54

328.18

ng/l

0.32

114

Menorrhagia

443

1.04

0.09

1.0

785.37

335.05

ng/l

0.55

313

Benign neoplasm: Caecum

299

0.94

0.09

1.1

1.0

269.56

350.29

ng/l

1.45

190

Secondary uncertain malignant neoplasm

299

0.94

0.09

1.0

328.55

321.57

ng/l

0.05

199

Acute upper respiratory infections of multiple and unspecified sites

180

1378

0.98

0.09

1.0

258.04

342.40

ng/l

2.09

135

980

Other and unspecified disorders of vitreous body

132

1280

1.03

0.09

1.0

331.43

354.46

ng/l

0.28

903

Infective dermatitis

268

0.93

0.09

1.0

280.88

318.17

ng/l

0.36

184

Tuberculosis, wide

155

1.10

0.09

1.1

1.0

249.30

314.94

ng/l

—

Unspecified jaundice

1.13

0.09

1.0

396.50

317.67

ng/l

—

Glaucoma, exfoliation

237

0.93

0.09

1.0

376.73

311.47

ng/l

0.40

147

Diabetes mellitus in pregnancy

174

0.93

0.09

1.0

258.61

295.48

ng/l

0.53

140

Injuries involving multiple body regions

1.11

0.09

1.0

282.67

288.66

ng/l

—

Suggestive for eosinophilic asthma

237

0.93

0.09

1.0

355.71

324.71

ng/l

0.25

158

Inflammatory bowel disease treatment related agents

335

1874

1.02

0.09

1.0

320.28

329.10

ng/l

0.11

243

1338

Gestational [pregnancy-induced] hypertension

340

1.06

0.08

1.1

1.0

311.96

345.75

ng/l

0.34

254

Other and unspecified disease of Bartholin gland

1.03

0.08

1.0

289.17

347.92

ng/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

318

0.94

0.08

1.0

331.35

332.67

ng/l

0.01

215

Benign neoplasm: Parotid gland

185

0.92

0.08

1.1

1.0

371.00

311.45

ng/l

0.35

120

Postprocedural endocrine and metabolic disorders, not elsewhere classified

224

1.07

0.08

1.0

246.76

356.73

ng/l

1.36

152

Hernia of abdominal wall, postoperative

430

1.05

0.08

1.0

255.19

330.45

ng/l

1.58

340

Nontoxic multinodular goitre

501

0.96

0.08

1.0

337.57

358.55

ng/l

0.14

347

Retinal breaks without detachment

440

1.05

0.08

1.0

367.23

321.53

ng/l

0.57

303

Lymphoid leukaemia

123

0.89

0.08

1.2

1.0

242.40

318.00

ng/l

—

Other secondary coxarthrosis

1.05

0.08

1.0

898.86

297.16

ng/l

—

Cutaneous abscess, furuncle and carbuncle

539

1.04

0.08

1.0

248.97

315.93

ng/l

1.46

384

Other specified/unspecified dorsopathies

1.03

0.08

1.1

1.0

283.00

338.96

ng/l

—

Other specified and unspecified disorders of eye and adnexa

1.03

0.07

1.0

413.57

293.12

ng/l

—

Other complications of surgical and medical care, not elsewhere classified

205

1.07

0.07

1.0

327.00

320.06

ng/l

0.03

132

Hypokalaemia

254

1.06

0.07

1.0

1603.58

345.13

ng/l

0.43

168

Benign neoplasm: Pancreas

0.84

0.07

1.0

211.50

377.90

ng/l

—

Blepharochalasis

816

1.03

0.07

1.0

301.31

340.61

ng/l

0.72

550

Vascular disorders of the intestines

137

1.09

0.07

1.0

252.63

302.93

ng/l

—

909

1.03

0.07

1.0

274.98

323.49

ng/l

0.74

634

Other benign neoplasms of skin

100

976

1.02

0.07

1.0

344.77

332.22

ng/l

0.13

672

Viral infections characterized by skin and mucous membrane lesions

963

0.98

0.07

1.1

1.0

243.61

320.66

ng/l

3.81

672

Benign neoplasm of ovary

468

0.96

0.07

1.0

280.91

358.54

ng/l

1.53

322

Degeneration of macula and posterior pole

131

1102

0.98

0.06

1.0

339.37

333.84

ng/l

0.08

720

Benign leiomyoma with endometriosis

417

0.96

0.06

1.0

370.32

365.39

ng/l

0.03

277

Medical abortion

142

787

0.98

0.06

1.0

372.15

376.51

ng/l

0.03

101

568

All dysplastic lesions of the cervix uteri, vagina or vulva

384

0.96

0.06

1.0

242.69

333.80

ng/l

2.61

284

Otosclerosis

183

0.93

0.06

1.0

553.40

314.50

ng/l

—

117

Other disorders of teeth and supporting structures

528

0.97

0.06

1.0

331.42

340.10

ng/l

0.09

365

Other specified/unspecified arthritis

679

0.97

0.06

1.0

371.00

318.54

ng/l

0.23

470

Thyrotoxicosis, other and/or unspecified

416

0.96

0.06

1.0

256.13

357.34

ng/l

1.43

296

Acute suppurative otitis media

276

1.05

0.06

1.1

1.0

241.00

302.50

ng/l

1.68

182

Embedded and impacted teeth

181

0.94

0.06

1.0

222.77

278.20

ng/l

0.92

123

Diseases of salivary glands

456

0.96

0.05

1.0

272.41

344.21

ng/l

1.91

321

Atrophic disorders of skin

304

0.95

0.05

1.0

316.39

346.64

ng/l

0.22

210

Endometriosis of ovary

323

0.96

0.05

1.0

340.09

328.19

ng/l

0.08

229

Nontoxic goitre/thyroid nodule

768

0.98

0.05

1.0

324.38

330.62

ng/l

0.06

529

Adverse effects, not elsewhere classified

366

1.04

0.05

1.1

1.0

323.81

333.88

ng/l

0.08

257

Erosion of teeth, including avohilmo

363

1.04

0.05

1.0

287.68

338.66

ng/l

0.62

267

Other blood glucose lowering drugs, excl. Insulins

465

1.03

0.05

1.0

341.57

339.45

ng/l

0.01

313

Coxarthrosis, primary

185

1626

0.99

0.05

1.0

338.77

349.61

ng/l

0.08

117

1125

Pre-eclampsia or poor fetal growth

433

0.97

0.05

1.0

1191.58

333.04

ng/l

0.51

318

Preparation and fitting of bite rail to mouth

272

0.96

0.04

1.0

312.89

317.01

ng/l

0.03

194

Other and unspecified local infections of skin and subcutaneous tissue

201

0.95

0.04

1.0

272.31

329.63

ng/l

0.77

131

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

644

1.02

0.04

1.0

269.15

313.15

ng/l

0.81

476

Other diseases of stomach and duodenum

150

1.07

0.04

1.0

473.45

295.65

ng/l

0.91

Unspecified/other endometriosis

1.10

0.04

1.0

283.10

381.21

ng/l

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

160

0.94

0.04

1.0

2026.67

323.55

ng/l

0.47

Spontaneous abortion

678

0.98

0.04

1.0

302.17

378.60

ng/l

0.73

506

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

297

1917

1.01

0.04

1.0

345.22

330.99

ng/l

0.17

197

1386

Disorders of optic nerve and visual pathways

170

1.06

0.04

1.0

305.15

310.44

ng/l

0.04

108

Sequelae with surgical and medical care as external cause

487

1.03

0.04

1.0

249.11

330.78

ng/l

2.47

332

Foreign body or object entering through skin

119

0.92

0.04

1.1

1.0

178.82

271.53

ng/l

2.44

Ethmoidectomy

301

0.96

0.03

1.0

286.50

328.68

ng/l

0.60

211

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

153

1546

0.99

0.03

1.0

308.66

345.76

ng/l

0.52

111

1078

Dyspnoea

259

1968

1.01

0.03

1.0

406.13

322.00

ng/l

0.25

180

1403

Benign neoplasm: Caecum

270

1.04

0.03

1.1

1.0

269.56

323.29

ng/l

0.84

175

Seborrhoeic keratosis

592

0.98

0.03

1.0

279.46

336.83

ng/l

1.08

409

Benign lipomatous neoplasm

853

0.98

0.03

1.0

332.67

326.48

ng/l

0.07

585

Glomerulonephritis

219

0.96

0.03

1.1

1.0

333.13

306.46

ng/l

0.15

147

Methotrexate

370

0.97

0.03

1.0

402.81

343.83

ng/l

0.47

265

Other or unspecified ileus, impaction or obstruction

450

1.02

0.02

1.0

282.48

325.46

ng/l

0.83

310

Chondropathies

321

1.03

0.02

1.0

268.59

328.41

ng/l

1.21

229

Other diseases of blood and blood-forming organs

168

0.95

0.02

1.0

302.55

299.33

ng/l

0.01

105

Atrial fibrillation and flutter

102

658

1.01

0.02

1.0

339.08

342.58

ng/l

0.04

505

Deep bite

138

0.95

0.02

1.0

307.00

294.25

ng/l

—

Bronchiectasis

208

0.96

0.02

1.0

330.07

326.95

ng/l

0.02

129

Other local infections of skin and subcutaneous tissue

218

0.96

0.02

1.0

272.31

323.69

ng/l

0.68

146

Familial hypercholesterolemia, with ischemic heart disease

248

0.97

0.02

1.0

251.31

321.72

ng/l

1.19

164

Migraine, single triptan purchase ok & required. ICD-code if available is included

192

1308

0.99

0.02

1.0

285.99

339.43

ng/l

1.00

138

968

Triptan medication for migraine, single purchase ok

192

1308

0.99

0.02

1.0

285.99

339.43

ng/l

1.00

138

968

Paroxysmal tachycardia

489

0.99

0.01

1.1

1.0

286.44

346.99

ng/l

1.43

365

Nontoxic single thyroid nodule

163

1.04

0.01

1.0

328.08

351.53

ng/l

0.21

112

Artificial joint re-operation

173

1.04

0.01

1.1

1.0

274.42

317.82

ng/l

0.48

106

Contact with and exposure to communicable diseases

396

0.98

0.01

1.1

1.0

219.33

308.20

ng/l

2.38

283

Benign neoplasm: Rectum, anus and anal canal

592

1.01

0.01

1.0

314.76

339.38

ng/l

0.43

393

TMD related operations

333

1.02

0.01

1.0

304.80

335.47

ng/l

0.40

236

Benign neoplasm: Skin of eyelid, including canthus

417

0.98

0.01

1.1

1.0

324.18

352.11

ng/l

0.26

279

Dislocation, sprain and strain of joints and ligaments of knee

155

1432

1.01

0.01

1.0

308.22

332.59

ng/l

0.27

117

1039

Intestinal stricture

787

0.99

0.01

1.0

273.20

329.75

ng/l

1.90

537

Acute sinusitis

118

1093

1.01

0.01

1.0

273.84

347.51

ng/l

1.08

779

Mixed hyperlipidaemia

1.06

0.01

1.0

305.40

348.88

ng/l

—

Melanocytic naevi of other and unspecified parts of face

104

1.06

0.01

1.0

343.00

320.06

ng/l

—

Asthma and opportunity respiratory infection

106

0.94

0.01

1.0

296.40

334.06

ng/l

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

224

1.03

0.00

1.0

314.00

351.55

ng/l

0.24

139

Spontaneous rupture of synovium and tendon

204

1.03

0.00

1.0

399.67

355.48

ng/l

0.27

141

Diseases of peritoneum

236

0.97

0.00

1.0

255.29

326.83

ng/l

1.13

154

Angina pectoris

206

1386

1.00

0.00

1.0

271.96

331.13

ng/l

3.77

141

978

Presence of other functional implants

186

1312

1.00

0.00

1.0

328.23

334.54

ng/l

0.09

131

891

Benign neoplasm: Ascending colon

386

0.98

0.00

1.0

261.40

341.14

ng/l

1.64

248

Presbycusis

263

1.02

0.00

1.1

1.0

267.42

335.15

ng/l

1.65

158

Other nutritional deficiencies

160

1567

1.00

0.00

1.0

234.83

335.45

ng/l

3.64

117

1123

Sequelae of external causes of morbidity and mortality

604

0.99

0.00

1.0

255.05

332.82

ng/l

2.54

416

Umbilical hernia

684

0.99

0.00

1.0

306.75

308.90

ng/l

0.02

493

Pacemaker

828

1.00

0.00

1.0

309.25

333.50

ng/l

0.40

531

Superficial injury of shoulder and upper arm

218

1.01

0.00

1.0

267.56

316.86

ng/l

0.33

149

Melanocytic naevi of other and unspecified parts of face

115

0.96

0.00

1.0

343.00

345.20

ng/l

—

Intestinal adhesions without obstruction

195

1.03

0.00

1.0

240.77

323.91

ng/l

1.09

133

Pedal cyclist injured in other and unspecified transport accidents

225

0.98

0.00

1.0

248.60

318.61

ng/l

0.81

150

Benign neoplasm: Skin of other and unspecified parts of face

245

1.02

0.00

1.0

399.39

315.57

ng/l

0.39

164

Ptosis of eyelid

265

1.02

0.00

1.1

1.0

197.11

326.37

ng/l

4.78

175

FESS (DNB20)

285

1.02

0.00

1.0

286.50

332.05

ng/l

0.66

199

Leiomyoma of uterus

158

896

1.00

0.00

1.0

580.05

328.69

ng/l

0.60

120

643

Diabetic nephropathy

313

1.01

0.00

1.0

365.17

269.82

ng/l

0.95

210

False labour

191

0.99

0.00

1.0

236.30

304.71

ng/l

1.36

156

Acute peritonitis

126

1.03

0.00

1.0

238.17

289.48

ng/l

—

Fall on and from ladder

194

0.98

0.00

1.1

1.0

236.45

296.35

ng/l

0.60

131

Benign neoplasm of mouth and pharynx

284

0.99

0.00

1.1

1.0

205.50

345.08

ng/l

6.99

186

Other disorders of conjunctiva

346

1.01

0.00

1.0

343.32

318.76

ng/l

0.26

230

Inflammatory disease of uterus

197

1.02

0.00

1.0

312.07

348.60

ng/l

0.33

137

Suppurative and unspecified otitis media

451

1.00

0.00

1.0

285.41

307.71

ng/l

0.37

315

Dermatographic urticaria

108

1.02

0.00

1.0

403.83

311.25

ng/l

—

Other diseases of hard tissues of teeth

176

1316

1.00

0.00

1.0

272.44

324.32

ng/l

2.81

137

942

337

1781

1.00

0.00

1.0

278.03

349.72

ng/l

2.28

238

1263

Unspecified lump in breast

328

1.01

0.00

1.0

266.19

368.76

ng/l

2.24

231

Pre-eclampsia or eclampsia

372

0.99

0.00

1.1

1.0

1381.73

345.01

ng/l

0.51

274

Follicular cysts of skin and subcutaneous tissue

418

1.00

0.00

1.0

330.21

313.12

ng/l

0.10

298

Benign neoplasm of other and ill-defined parts of digestive system

502

1.00

0.00

1.0

342.66

339.01

ng/l

0.03

335

Complications of internal orthopaedic prosthetic devices, implants and grafts

598

1.00

0.00

1.0

273.43

336.72

ng/l

2.03

404

Localized swelling, mass and lump of skin and subcutaneous tissue

783

1.00

0.00

1.0

297.19

328.87

ng/l

0.57

543

Other diseases of lip and oral mucosa

391

1.00

0.00

1.1

1.0

333.47

341.55

ng/l

0.08

273

Benign neoplasm: Transverse colon

297

1.01

0.00

1.0

301.14

333.97

ng/l

0.40

192

Sequelae of injuries of lower limb

193

0.98

0.00

1.1

1.0

292.18

318.85

ng/l

0.22

128

Duodenal ulcer

250

1.00

0.00

1.0

315.42

318.50

ng/l

0.02

155

Benign neoplasm: Pancreas

1.00

0.00

1.0

211.50

267.32

ng/l

—

Other, unspecified and serous retinal detachments

1.00

0.00

1.1

1.0

248.57

270.18

ng/l

—

Ependymoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

293.43

—

Cyst of Bartholin Gland

0.95

0.00

1.3

1.0

293.00

358.82

ng/l

—

Hirsutism, drug-induced

0.00

0.0

1.0

—

221.20

—

Sulfasalazine

770

1.00

0.00

1.0

328.16

332.88

ng/l

0.04

548

Contact with other sharp object(s)

0.97

0.00

1.0

177.11

283.82

ng/l

—

Use of rasagiline

0.91

0.00

1.2

1.0

242.33

309.89

ng/l

—

Anaemia in chronic diseases classified elsewhere

0.94

0.00

1.0

364.20

256.89

ng/l

—

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

293.25

—

Crossbite

0.88

0.00

1.0

239.50

300.62

ng/l

—

Benign neoplasm: Lacrimal gland and duct

0.00

0.0

1.0

—

268.00

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Tau protein [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS